<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset>
	<article
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
		<?properties open_access?>
		<front>
			<journal-meta>
				<journal-id journal-id-type="nlm-ta">Autophagy</journal-id>
				<journal-id journal-id-type="iso-abbrev">Autophagy</journal-id>
				<journal-id journal-id-type="publisher-id">KAUP</journal-id>
				<journal-id journal-id-type="publisher-id">kaup20</journal-id>
				<journal-title-group>
					<journal-title>Autophagy</journal-title>
				</journal-title-group>
				<issn pub-type="ppub">1554-8627</issn>
				<issn pub-type="epub">1554-8635</issn>
				<publisher>
					<publisher-name>Taylor &amp; Francis</publisher-name>
				</publisher>
			</journal-meta>
			<article-meta>
				<article-id pub-id-type="pmid">30208760</article-id>
				<article-id pub-id-type="pmc">6351131</article-id>
				<article-id pub-id-type="publisher-id">1522467</article-id>
				<article-id pub-id-type="doi">10.1080/15548627.2018.1522467</article-id>
				<article-categories>
					<subj-group subj-group-type="heading">
						<subject>Research Paper - Basic Science</subject>
					</subj-group>
				</article-categories>
				<title-group>
					<article-title>
						<italic>Mir223</italic> restrains autophagy and promotes CNS inflammation by targeting ATG16L1
					</article-title>
					<alt-title alt-title-type="running-authors">Y. LI ET AL.</alt-title>
					<alt-title alt-title-type="running-title">AUTOPHAGY</alt-title>
				</title-group>
				<contrib-group>
					<contrib contrib-type="author">
						<name>
							<surname>Li</surname>
							<given-names>Yan</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Zhou</surname>
							<given-names>Dongmei</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Ren</surname>
							<given-names>Yinghui</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0002">
							<sup>b</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Zhang</surname>
							<given-names>Zimu</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Guo</surname>
							<given-names>Xiangdong</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Ma</surname>
							<given-names>MingKun</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
						<xref ref-type="aff" rid="AFF0003">
							<sup>c</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Xue</surname>
							<given-names>Zhenyi</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Lv</surname>
							<given-names>Jienv</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
						<xref ref-type="aff" rid="AFF0004">
							<sup>d</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Liu</surname>
							<given-names>Hongkun</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Xi</surname>
							<given-names>Qing</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Jia</surname>
							<given-names>Long</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Zhang</surname>
							<given-names>Lijuan</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Liu</surname>
							<given-names>Ying</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Zhang</surname>
							<given-names>Qi</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0005">
							<sup>e</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Yan</surname>
							<given-names>Jun</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0006">
							<sup>f</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Da</surname>
							<given-names>Yurong</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Gao</surname>
							<given-names>Fei</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0007">
							<sup>g</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Yue</surname>
							<given-names>Jianbo</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0008">
							<sup>h</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Yao</surname>
							<given-names>Zhi</given-names>
						</name>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Zhang</surname>
							<given-names>Rongxin</given-names>
						</name>
						<xref ref-type="corresp" rid="AN0001"/>
						<xref ref-type="aff" rid="AFF0001">
							<sup>a</sup>
						</xref>
						<xref ref-type="aff" rid="AFF0009">
							<sup>i</sup>
						</xref>
					</contrib>
					<aff id="AFF0001">
						<label>a</label>
						<institution>Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health), Tianjin Medical University</institution>, Tianjin,
						<country>China</country>
					</aff>
					<aff id="AFF0002">
						<label>b</label>
						<institution>Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital</institution>, Tianjin,
						<country>China</country>
					</aff>
					<aff id="AFF0003">
						<label>c</label>
						<institution>Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine</institution>, Tianjin,
						<country>China</country>
					</aff>
					<aff id="AFF0004">
						<label>d</label>
						<institution>Hexi Women &amp; Children Healthcare and Family Planning Service Center</institution>, Tianjin,
						<country>China</country>
					</aff>
					<aff id="AFF0005">
						<label>e</label>
						<institution>Institute of Integrative Medicines for Acute Abdominal Diseases, Nankai Hospital</institution>, Tianjin,
						<country>China</country>
					</aff>
					<aff id="AFF0006">
						<label>f</label>
						<institution>Tianjin Institute of Animal husbandry and veterinary</institution>, Tianjin,
						<country>China</country>
					</aff>
					<aff id="AFF0007">
						<label>g</label>
						<institution>State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences</institution>, Beijing,
						<country>China</country>
					</aff>
					<aff id="AFF0008">
						<label>h</label>
						<institution>Department of Biomedical Sciences, City University of Hong Kong</institution>, Hong Kong,
						<country>China</country>
					</aff>
					<aff id="AFF0009">
						<label>i</label>
						<institution>Guangdong Province Key Laboratory for Biotechnology Drug Candidates, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University</institution>, Guangzhou,
						<country>China</country>
					</aff>
				</contrib-group>
				<author-notes>
					<corresp id="AN0001">CONTACT Rongxin Zhang
						<email xlink:href="rxzhang@tmu.edu.cn">rxzhang@tmu.edu.cn</email>;
						<email xlink:href="rongxinz@yahoo.com">rongxinz@yahoo.com</email>; Zhi Yao
						<email xlink:href="yaozhi@tmu.edu.cn">yaozhi@tmu.edu.cn</email>
						<institution>Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Hormones and Development (Ministry of Health), Tianjin Medical University</institution>, Tianjin 300070,
						<country>China</country>
					</corresp>
				</author-notes>
				<pub-date pub-type="collection">
					<year>2019</year>
				</pub-date>
				<pub-date pub-type="epub">
					<day>22</day>
					<month>9</month>
					<year>2018</year>
				</pub-date>
				<pub-date pub-type="pmc-release">
					<day>22</day>
					<month>9</month>
					<year>2018</year>
				</pub-date>
				<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
				<volume>15</volume>
				<issue>3</issue>
				<fpage seq="9">478</fpage>
				<lpage>492</lpage>
				<history>
					<date date-type="received">
						<day>21</day>
						<month>4</month>
						<year>2017</year>
					</date>
					<date date-type="rev-recd">
						<day>22</day>
						<month>8</month>
						<year>2018</year>
					</date>
					<date date-type="accepted">
						<day>4</day>
						<month>9</month>
						<year>2018</year>
					</date>
				</history>
				<permissions>
					<copyright-statement>&#xA9; 2018 Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-statement>
					<copyright-year>2018</copyright-year>
					<copyright-holder>Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-holder>
					<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
						<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (
							<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
						</license-p>
					</license>
				</permissions>
				<self-uri content-type="pdf" xlink:href="kaup-15-03-1522467.pdf"/>
				<abstract>
					<title>ABSTRACT</title>
					<p>Microglia are innate immune cells in the central nervous system (CNS), that supplies neurons with key factors for executing autophagosomal/lysosomal functions. Macroautophagy/autophagy is a cellular catabolic process that maintains cell balance in response to stress-related stimulation. Abnormal autophagy occurs with many pathologies, such as cancer, and autoimmune and neurodegenerative diseases. Hence, clarification of the mechanisms of autophagy regulation is of utmost importance. Recently, researchers presented microRNAs (miRNAs) as novel and potent modulators of autophagic activity. Here, we found that
						<italic>Mir223</italic> deficiency significantly ameliorated CNS inflammation, demyelination and the clinical symptoms of experimental autoimmune encephalomyelitis (EAE) and increased resting microglia and autophagy in brain microglial cells. In contrast, the autophagy inhibitor 3-methylademine (3-MA) aggravated the clinical symptoms of EAE in wild-type (WT) and
						<italic>Mir223</italic>-deficienct mice. Furthermore, it was confirmed that
						<italic>Mir223</italic> deficiency in mice increased the protein expression of ATG16L1 (autophagy related 16-like 1 [S. cerevisiae]) and LC3-II in bone marrow-derived macrophage cells compared with cells from WT mice. Indeed, the cellular level of
						<italic>Atg16l1</italic> was decreased in BV2 cells upon
						<italic>Mir223</italic> overexpression and increased following the introduction of antagomirs. We also showed that the 3&#x2019; UTR of
						<italic>Atg16l1</italic> contained functional
						<italic>Mir223</italic>-responsive sequences and that overexpression of ATG16L1 returned autophagy to normal levels even in the presence of
						<italic>Mir223</italic> mimics. Collectively, these data indicate that
						<italic>Mir223</italic> is a novel and important regulator of autophagy and that
						<italic>Atg16l1</italic> is a
						<italic>Mir223</italic> target in this process, which may have implications for improving our understanding of the neuroinflammatory process of EAE.
					</p>
					<p>
						<bold>Abbreviations:</bold> 3-MA: 3-methylademine; ACTB/&#x3B2;-actin: actin, beta; ATG: autophagy related; ATG16L1: autophagy related 16-like 1 (S. cerevisiae); BECN1: beclin 1, autophagy related; CNR2: cannabinoid receptor 2 (macrophage); CNS: central nervous system; CQ: chloroquine; EAE: experimental autoimmune encephalomyelitis; FOXO3: forkhead box O3; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; H&amp;E: hematoxylin and eosin; ITGAM: integrin alpha M; LPS: lipoplysaccharide; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; miRNAs: microRNAs; MS: multiple sclerosis; PPARG: peroxisome proliferator activated receptor gamma; PTPRC: protein tyrosine phosphatase, receptor type, C; RA: rheumatoid arthritis; SQSTM1: sequestosome 1; TB: tuberculosis; TIMM23: translocase of inner mitochondrial membrane 23; TLR: toll-like receptor.
					</p>
				</abstract>
				<kwd-group kwd-group-type="author">
					<title>KEYWORDS</title>
					<kwd>ATG16L1</kwd>
					<kwd>autophagy</kwd>
					<kwd>CNS inflammation</kwd>
					<kwd>experimental autoimmune encephalomyelitis</kwd>
					<kwd>microglia</kwd>
					<kwd>
						<italic>Mir223</italic>
					</kwd>
				</kwd-group>
				<funding-group>
					<award-group>
						<funding-source>
							<named-content content-type="funder-name">National Natural Science Foundation of China</named-content>
							<named-content content-type="funder-identifier">10.13039/501100001809</named-content>
						</funding-source>
						<award-id>31600730</award-id>
						<award-id>81602496</award-id>
						<award-id>81501036</award-id>
						<award-id>81301026</award-id>
						<award-id>81302568</award-id>
						<award-id>81541032</award-id>
					</award-group>
					<award-group>
						<funding-source>
							<named-content content-type="funder-name">Postdoctoral Foundation of China</named-content>
						</funding-source>
						<award-id>2016M591396</award-id>
					</award-group>
					<award-group>
						<funding-source>
							<named-content content-type="funder-name">Science Foundation of Tianjin Medical University</named-content>
						</funding-source>
						<award-id>2012KYQ11</award-id>
					</award-group>
					<award-group>
						<funding-source>
							<named-content content-type="funder-name">Natural Science Foundation of Tianjin</named-content>
							<named-content content-type="funder-identifier">10.13039/501100006606</named-content>
						</funding-source>
						<award-id>16JCYBJC24800</award-id>
						<award-id>16JCYBJC24600</award-id>
					</award-group>
					<funding-statement>This work was supported by the National Natural Science Foundation of China through No. 31600730, 81602496, 81501036, 81301026, 81302568, 81541032; Natural Science Foundation of Tianjin through Grant No. 16JCYBJC24800, 16JCYBJC24600; Science Foundation of Tianjin Medical University through Grant No.2012KYQ11; Postdoctoral Foundation of China through Grant 2016M591396.</funding-statement>
				</funding-group>
				<counts>
					<fig-count count="8"/>
					<ref-count count="56"/>
					<page-count count="15"/>
				</counts>
			</article-meta>
		</front>
		<body>
			<sec sec-type="intro" id="S0001">
				<title>Introduction</title>
				<p>EAE is the classical mouse model of human multiple sclerosis (MS), a chronic inflammatory disease that is characterized by demyelination and degeneration of axonal destruction in the CNS. Although the etiopathogenesis has not been well elucidated, a cascade of studies shows that EAE is trigged by the disruption of the blood-brain-barrier, as well as the activation of microglia and lymphocytes [
					<xref rid="CIT0001">1</xref>&#x2013;
					<xref rid="CIT0004">4</xref>].
				</p>
				<p>Microglia are the first line of defense in the CNS; they belong to the mononuclear phagocytic family and serve to clear pathogens in the initiation and sustenance of neuro-inflammation. The functions of microglia in MS are complex and not well understood, though it has been well established that microglia contribute significantly to the overall disease severity of MS. In fact, activated microglial nodules are the hallmark of MS lesion formation [
					<xref rid="CIT0005">5</xref>]. Overactive microglia are responsible for detrimental effects leading to profound neurological impairments [
					<xref rid="CIT0006">6</xref>], most of which occur by damage to the mitochondria.
				</p>
				<p>It has been reported recently that enhancement of autophagy could ameliorate the pathogenesis of MS or EAE disease through the limitation of neuro-in&#xFB02;ammation [
					<xref rid="CIT0007">7</xref>&#x2013;
					<xref rid="CIT0009">9</xref>]. Neuro-inflammation and autophagy are 2 critical cellular processes that regulate each other to affect the progression of various diseases in the CNS. The relationship between these 2 processes is complex and includes the suppression of neuro-inflammation by autophagy. However, the signaling mechanisms that relieve this autophagy-mediated inhibition of inflammation to permit a beneficial inflammatory response remain unknown. Recent research found that regulating microglial activation by modulating mitophagy contributes to neuronal survival in Parkinson disease [
					<xref rid="CIT0010">10</xref>], and microglia autophagy plays an important role in the regulation of Parkinson disease [
					<xref rid="CIT0011">11</xref>]. In addition, inhibition of neuro-inflammation by autophagy has great benefits in ischemia [
					<xref rid="CIT0012">12</xref>].
				</p>
				<p>Autophagy is a highly conserved catabolic pathway in the cell that degrades and recycles long-lived proteins and damaged organelles through lysosomal digestion [
					<xref rid="CIT0013">13</xref>]. Autophagy is active at a basal level under normal conditions, but it is rapidly upregulated following exposure to stress factors, including nutrient/hormone deprivation, hypoxic stress, accumulation of misfolded proteins and bacterial invasion [
					<xref rid="CIT0014">14</xref>,
					<xref rid="CIT0015">15</xref>]. Autophagy plays important roles in various organismal processes, such as development and aging, whereas abnormal autophagy leads to pathologies, including autoimmune and neurodegenerative diseases and cancer [
					<xref rid="CIT0016">16</xref>&#x2013;
					<xref rid="CIT0019">19</xref>]. It has been reported that inducing autophagy could ameliorate several neurodegenerative diseases [
					<xref rid="CIT0020">20</xref>,
					<xref rid="CIT0021">21</xref>], and inhibit in&#xFB02;ammation, especially in in&#xFB02;ammatory or immune cells such as macrophages and dendritic cells [
					<xref rid="CIT0022">22</xref>,
					<xref rid="CIT0023">23</xref>].
				</p>
				<p>Autophagy involves the formation of double-membrane vesicles in the cytosol called autophagosomes. These autophagosomes eventually fuse with lysosomes to form autolysosomes, where they are degraded and recycled [
					<xref rid="CIT0013">13</xref>,
					<xref rid="CIT0024">24</xref>]. However, the exact assembly platform and membrane source for the generation of these initial structures are still debated. The most likely organelles to provide membranes include specialized phosphatidylinositol-3-phosphate-enriched endoplasmic reticulum domains the Golgi apparatus. There are several important protein complexes that play a key role during autophagosome formation, including the ULK1 (unc-51 like kinase 1) complex, the class III phosphatidylinositol 3-kinase complex, ATG2-WIPI (WD repeat domain, phosphoinositide-interacting) protein complex, the ATG9 cycling system, and the ATG12&#x2013;ATG5-ATG16L1 and MAP1LC3/LC3 (microtubule associated protein 1 light chain 3) or GABARAP conjugation systems [
					<xref rid="CIT0025">25</xref>]. Mitophagy, a classic type of cargo-specific autophagy, is the process of catabolism of mitochondria through their encapsulation by compartments termed phagophores (the precursors to autophagosomes) that are coated with the marker LC3 [
					<xref rid="CIT0026">26</xref>]. LC3 protein is covalently conjugated to the lipid phosphatidylethanolamine on the surface of phagophores [
					<xref rid="CIT0027">27</xref>]. LC3 must be cleaved by ATG4 proteins before conjugation with phosphatidylethanolamine [
					<xref rid="CIT0028">28</xref>,
					<xref rid="CIT0029">29</xref>]. While free LC3 (also called LC3-I) is soluble, its lipid-conjugated form (LC3-II) is associated with phagophores and complete autophagosomes. Hence, LC3 conjugation is used as a molecular marker of autophagosome generation and accumulation [
					<xref rid="CIT0030">30</xref>]. Chloroquine (CQ) is considered a lysosomotropic agent that can be trapped in lysosomes to inhibit lysosomal acidification and the activity of the degradative enzymes. Therefore, cells treated with CQ cannot undergo lysosomal digestion and exhibit autophagic vacuole accumulation [
					<xref rid="CIT0031">31</xref>].
				</p>
				<p>The mechanisms regulating mammalian autophagy still require further investigation. Accumulating data have indicated that miRNAs play an important role in autophagy regulation [
					<xref rid="CIT0032">32</xref>,
					<xref rid="CIT0033">33</xref>]. miRNAs control biological events either by triggering the degradation of their target mRNAs through recognition of specific sequences, miRNA response elements (MREs), in the 3&#x2019; UTR, and/or through inhibition of their translation. Recent reports have provided evidence that under stress conditions, a number of miRNAs, including
					<italic>Mir144</italic> [
					<xref rid="CIT0034">34</xref>],
					<italic>Mir142, Mir106, Mir93</italic>, and
					<italic>Mir20</italic>, are capable of modulating autophagy by changing the intracellular levels of key autophagy proteins.
					<italic>Mir223</italic> plays roles in monocytes/macrophages and embryonic stem cell differentiation, osteoclast formation, and bone remodeling. Microarray analyses of miRNA expression found that
					<italic>Mir223</italic> is enriched in microglia [
					<xref rid="CIT0035">35</xref>] and significantly upregulated in MS patients, and therefore the
					<italic>MIR223</italic> expression profile is a promising diagnostic biomarker for MS [
					<xref rid="CIT0036">36</xref>].
					<italic>mir223</italic> knockout (
					<italic>mir223</italic>
					<sup>&#x2212;/-</sup>) mice develop less severe EAE, with increased myeloid-derived suppressor cell numbers in the spleen and spinal cord [
					<xref rid="CIT0037">37</xref>].
				</p>
				<p>However, whether autophagy in microglia plays a role in the
					<italic>mir223</italic>
					<sup>&#x2212;/ &#x2013;</sup> mediated alleviation of neuro-in&#xFB02;ammation remains unclear. Here, we discovered that
					<italic>Mir223</italic> deficiency significantly ameliorated CNS inflammation, demyelination and the clinical symptoms of EAE and increased the number of resting microglia and the amount of autophagy in brain microglial cells. In contrast, the autophagy inhibitor 3-MA aggravated the clinical symptoms of EAE in WT and
					<italic>mir223</italic>
					<sup>&#x2212;/-</sup> mice. Furthermore, we discovered that
					<italic>Mir223</italic> blocked starvation- and lipoplysaccharide (LPS)-induced autophagy in microglial BV2 cell lines. In light of our results, we provide evidence that a key autophagy protein, ATG16L1, is an important and direct autophagy-related target of
					<italic>Mir223</italic>.
				</p>
			</sec>
			<sec id="S0002">
				<title>Results</title>
				<sec id="S0002-S2001">
					<title>
						<italic>Mir223</italic> deficiency suppresses pathogenic CNS inflammation and demyelination during EAE progression in mice
					</title>
					<p>Previously, several studies demonstrated that certain miRNAs play an important role in the regulation of autoimmunity. One report found that
						<italic>Mir223</italic> regulates EAE though myeloid-derived suppressor cells. We wanted to investigate whether endogenous
						<italic>Mir223</italic> levels affected the clinical symptoms of EAE in C57BL/6 mice immunized with the MOG[
						<xref rid="CIT0035">35</xref>&#x2013;
						<xref rid="CIT0055">55</xref>] peptide as well as the mechanism involved. Interestingly, knockout of
						<italic>Mir223</italic> (
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup>) significantly ameliorated the clinical symptoms of EAE compared with wild-type C57BL/6 mice (
						<xref rid="F0001">Figure 1A, B</xref> and
						<xref rid="F0001">C</xref>). In addition, disease severity, as assessed by the maximal and cumulative clinical score, was significantly decreased in
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice (
						<xref rid="F0001">Figure 1D</xref> and
						<xref rid="F0001">E</xref>). These data suggest that endogenous
						<italic>Mir223</italic> levels affect the clinical outcome of EAE.
						<fig id="F0001" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0001</object-id>
							<label>Figure 1.</label>
							<caption>
								<p>
									<italic>mir223</italic>
									<sup>&#x2212;/-</sup> mice have alleviated EAE symptoms and decreased spinal cord inflammation and demyelination. EAE was induced with MOG[
									<xref rid="CIT0035">35</xref>&#x2013;
									<xref rid="CIT0055">55</xref>] in female C57BL/6 mice (n&#xA0;=&#xA0;12). The clinical scores of all of the EAE mice were assessed daily according to the same criteria for 28 continuous days. Incidence (
									<bold>A</bold>), disease onset (
									<bold>B</bold>), daily clinical scores (
									<bold>C</bold>), peak disease scores (
									<bold>D</bold>), and cumulative disease scores (
									<bold>E</bold>) were monitored. (
									<bold>A</bold>) The incidence of EAE (mice with clinical score &#x2265;&#xA0;1 for 2 continuous days). The disease incidence is represented by the percentage of mice suffering from EAE. (
									<bold>B</bold>) Line graph depicts the EAE survival rate between WT and
									<italic>mir223</italic>
									<sup>&#x2212;/-</sup> mice. (
									<bold>C</bold>) The clinical scores of all of the mice for 28 continuous days. (
									<bold>D</bold>) The mean maximum clinical scores. (
									<bold>E</bold>) The mean disease cumulative score. (
									<bold>F</bold>) H&amp;E staining of representative spinal cord sections from
									<italic>mir223</italic>
									<sup>&#x2212;/-</sup> mice and WT mice shows the infiltration of inflammatory cells in the white matter. (
									<bold>G</bold>) Luxol fast blue staining of intact myelin (blue) and demyelination (pink). The data are representative of at least 2 experiments with similar results.
								</p>
							</caption>
							<graphic content-type="color" xlink:href="kaup-15-03-1522467-g001"/>
						</fig>
					</p>
					<p>To characterize disease progression at the level of CNS injury, we performed a histological analysis of the lumbar spinal cord on day 15 post-immunization. At the peak of the acute phase of EAE, hematoxylin and eosin (H&amp;E) and luxol fast blue staining showed that there was less infiltration of mononuclear cells and decreased demyelination in the lumbar spinal cords of
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice compared with wild-type mice (
						<xref rid="F0001">Figure 1F</xref> and
						<xref rid="F0001">G</xref>). Thus,
						<italic>Mir223</italic> deficiency improves the pathological and clinical symptoms of EAE.
					</p>
				</sec>
				<sec id="S0002-S2002">
					<title>
						<italic>Mir223</italic> deficiency augments autophagy and resting microglia in EAE mice
					</title>
					<p>Microglial cells play important roles in the regulation of EAE and MS. We assessed whether
						<italic>Mir223</italic> affects microglia in the CNS of EAE mice. Deficiency of
						<italic>Mir223</italic> decreased the infiltration of ITGAM
						<sup>+</sup> and PTPRC
						<sup>+</sup> cells and especially increased the PTPRC
						<sup>low</sup> and decreased the PTPRC
						<sup>hi</sup> cells. Overactive microglia can lead to profound neurological impairment. Here, we found that
						<italic>Mir223</italic> deficiency reduced the number of active microglia and macrophages (ITGAM
						<sup>+</sup> PTPRC
						<sup>hi</sup>) but increased the number of resting microglia (ITGAM
						<sup>+</sup> PTPRC
						<sup>low</sup>). There was also an augmentation of the ratio of the resting microglia vs the active microglia and macrophages in
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice (
						<xref rid="F0002">Figure 2A</xref> and
						<xref rid="F0002">B</xref>).
						<fig id="F0002" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0002</object-id>
							<label>Figure 2.</label>
							<caption>
								<p>
									<italic>Mir223</italic> deficiency increased autophagy and resting microglia in the brains of EAE mice. (
									<bold>A</bold>) Flow cytometric analysis of microglia, demonstrating PTPRC and ITGAM cells isolated from the CNS of EAE mice (n&#xA0;=&#xA0;6 mice per group), detected on the 15th day after the induction of EAE. The data are shown in a representative plot. (
									<bold>B</bold>) The absolute numbers of the cell subpopulations are shown; the black column is for
									<italic>mir223</italic>
									<sup>&#x2212;/-</sup> mice. Rest, ITGAM
									<sup>+</sup> PTPRC
									<sup>low</sup>; mc, ITGAM
									<sup>+</sup> PTPRC
									<sup>hi and low</sup>. (
									<bold>C</bold>) Autophagy was measured in the brains of the mice. LC3 puncta were visualized by confocal imaging of microglia immunostained for LC3 and AIF1, followed by Alexa Fluor 488/555-conjugated secondary antibodies (green/red); nuclei were stained with DAPI. Representative images are shown. Scale bars: 20&#xA0;&#xB5;m. (
									<bold>D</bold>) and (
									<bold>E</bold>) BCL2 and BECN1 expression were visualized by fluorescence imaging of microglia. Scale bars: 50&#xA0;&#xB5;m.
								</p>
							</caption>
							<graphic content-type="color" xlink:href="kaup-15-03-1522467-g002"/>
						</fig>
					</p>
					<p>There were considerably higher levels of LC3 protein in the microglia in the brains of
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice than in wild-type mouse controls in the acute phase of EAE (
						<xref rid="F0002">Figure 2C</xref>). In contrast, BCL2 and BECN1/Beclin1 expression did not differ between the WT and
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice (
						<xref rid="F0002">Figure 2D</xref> and
						<bold>E</bold>). It is possible that
						<italic>Mir223</italic> may regulate microglia autophagy though pathways other than BCL2 and BECN1, which remain unclear.
					</p>
				</sec>
				<sec id="S0002-S2003">
					<title>3-MA-mediated blockade of autophagy attenuates the protective effects of
						<italic>Mir223</italic> on EAE mice
					</title>
					<p>To determine the influence of autophagy on the effects of
						<italic>Mir223</italic> on the progression of MS
						<italic>in vivo</italic>, we examined neurobehavioral deficits in 3-MA- and vehicle-treated mice following MOG[
						<xref rid="CIT0035">35</xref>&#x2013;
						<xref rid="CIT0055">55</xref>]-mediated induction of EAE. As shown in
						<xref rid="F0003">Figure 3</xref>, the disease course in the EAE mouse model was a chronic progressive-relapsing phenotype.
						<italic>Mir223</italic> deficiency significantly reduced the severity of neurobehavioral deficits, cumulative scores, and maximum neurological disability in EAE mice compared with WT mice. The effect of
						<italic>Mir223</italic> was abolished by 3-MA (10&#x2009;mg/kg), an autophagy inhibitor (
						<xref rid="F0003">Figure 3A</xref>-
						<xref rid="F0003">3F</xref>), suggesting that
						<italic>Mir223</italic> plays a role in the progression of EAE at least partly through its effects on autophagy.
						<fig id="F0003" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0003</object-id>
							<label>Figure 3.</label>
							<caption>
								<p>3-MA-mediated blockade of autophagy attenuates the effects of
									<italic>Mir223</italic> on EAE mice. EAE was induced with MOG[
									<xref rid="CIT0035">35</xref>&#x2013;
									<xref rid="CIT0055">55</xref>] in female C57BL/6 mice (n&#xA0;=&#xA0;12). Mice were injected with 3-MA every day after immunization. The body weight and clinical scores of all of the EAE mice were assessed daily according to the same criteria for 21 continuous days. Body weight (
									<bold>A</bold>), disease onset (
									<bold>B</bold>), incidence (
									<bold>C</bold>), peak disease scores (
									<bold>D</bold>), daily clinical scores (
									<bold>E</bold>), and cumulative disease scores (
									<bold>F</bold>) were monitored.
								</p>
							</caption>
							<graphic specific-use="web-only" content-type="color" xlink:href="kaup-15-03-1522467-g003"/>
						</fig>
					</p>
				</sec>
				<sec id="S0002-S2004">
					<title>
						<italic>Mir223</italic> deficiency promotes autophagy in microphages and BV2 microglial cells stimulated with LPS
					</title>
					<p>Knockout of
						<italic>Mir223</italic> increased autophagy in microglia and resting microglia in the CNS during EAE progression. We differentiated macrophage cells from the bone marrow cells of wild-type C57BL/6 mice or
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice
						<italic>in vitro</italic> to confirm that
						<italic>Mir223</italic> blocks autophagy in microglial cells upon LPS or starvation treatment. LC3 protein expression was increased in bone marrow-derived macrophage cells after stimulation with LPS or starvation, and ATG16L1 protein was mostly increased in
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mouse macrophages compared with those from wild-type mice (
						<xref rid="F0004">Figure 4A</xref>). Moreover, a
						<italic>Mir223</italic> inhibitor induced the production of autophagosomes and autolysosomes upon LPS stimulation in microglial BV2 cells (
						<xref rid="F0004">Figure 4B</xref> and
						<xref rid="F0004">C</xref>). These data indicate that endogenous
						<italic>Mir223</italic> can affect autophagy through the ATG16L1-LC3 pathway during EAE progression.
						<fig id="F0004" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0004</object-id>
							<label>Figure 4.</label>
							<caption>
								<p>
									<italic>Mir223</italic> deficiency increases autophagy in primary macrophages and BV2 cells. (
									<bold>A</bold>) Macrophages were separated from the bone marrow of WT mice and
									<italic>mir223</italic>
									<sup>&#x2212;/-</sup> mice. The cells were stimulated with LPS or starvation. Immunoblot analysis was performed for ATG16L1, SQSTM1, TIMM23, LC3 and ACTB. ATG16L1:ACTB and LC3-II:ACTB ratios are shown below the blots. (
									<bold>B</bold>) Deficiency of
									<italic>Mir223</italic> induces autophagic vacuoles in BV2 cells upon LPS stimulation. Scale bars: 0.5&#xA0;&#xB5;m. (
									<bold>C</bold>) Quantitative analysis of the number of autophagic vacuoles.
								</p>
							</caption>
							<graphic specific-use="web-only" content-type="color" xlink:href="kaup-15-03-1522467-g004"/>
						</fig>
					</p>
				</sec>
				<sec id="S0002-S2005">
					<title>
						<italic>Mir223</italic> blocks LPS-induced autophagy in BV2 cells
					</title>
					<p>Recent advances have revealed a relationship between autophagy and innate immunity. Autophagy plays a crucial role in sustaining the balance between the beneficial and detrimental effects of immunity and inflammation [
						<xref rid="CIT0038">38</xref>]. It has been reported that LPS induces a non-typical autophagy pathway in BV2 microglia; however, the activation of the typical autophagy pathway using rapamycin inhibits the expression of NOS2 (nitric oxide synthase 2, inducible), IL6 (interleukin 6), and the cell death of microglia exposed to LPS [
						<xref rid="CIT0039">39</xref>]. Autophagy defects, resulting from nutrient deprivation or dysfunction of the autophagy-related proteins, may increase the degree of microglial activation and inflammation.
					</p>
					<p>We then evaluated whether
						<italic>Mir223</italic> overexpression had an effect on LPS-induced autophagy. Past studies have suggested a link between toll-like receptor (TLR) signaling and autophagy in macrophages and other cell types via activation of downstream signaling pathways. TLR4 responds specifically to LPS stimulation. The autophagosome emanates from this signaling platform, and the membrane source for the generation of these initial structures is still debated. The most likely organelles to provide membranes include specialized phosphatidylinositol-3-phosphate-enriched endoplasmic reticulum domains and the Golgi apparatus. Here, we used the mitochondrial proteins TIMM23 and SQSTM1 (sequestosome 1) as a readout for autophagy. LPS-induced GFP-LC3 accumulation (
						<xref rid="F0005">Figure 5A</xref> and
						<xref rid="F0005">B</xref>), LC3 lipidation (
						<xref rid="F0005">Figure 5C</xref>) and TIMM23 degradation (
						<xref rid="F0005">Figure 5D</xref>) were decreased following
						<italic>Mir223</italic> overexpression. However, the expression of SQSTM1 did not cause any changes in BV2 cells during LPS stimulation. Cheng et al. found that
						<italic>MIR181A</italic> suppresses mitochondrial uncoupler-induced degradation of TIMM23 in SH-SY5Y human neuroblastoma cells, whereas SQSTM1 is not a reliable marker [
						<xref rid="CIT0040">40</xref>], and our results are consistent with these findings. Therefore, we concluded that
						<italic>Mir223</italic> inhibited LPS-induced autophagic activity in BV2 cells.
						<fig id="F0005" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0005</object-id>
							<label>Figure 5.</label>
							<caption>
								<p>Overexpression of
									<italic>Mir223</italic> blocks lipopolysaccharide-induced autophagy in BV2 cells. (
									<bold>A</bold>)
									<italic>Mir223</italic> repressed the formation of starvation-induced GFP-LC3 puncta in BV2 cells. Stable GFP-LC3-expressing cells were cotransfected with mimics or Mim-CN, and autophagy was evaluated after LPS or control treatment for 4&#xA0;h. Scale bar: 5 &#x3BC;m. (
									<bold>B</bold>) Quantitative analysis of the number of GFP-LC3 puncta per cell in (
									<bold>A</bold>). The data are presented as the mean&#xB1;&#xA0;SEM; experiments were performed in triplicate (*
									<italic>p&#xA0;</italic>&lt;&#xA0;0.05, **
									<italic>p&#xA0;</italic>&lt;&#xA0;0.01; NS, not significant). (
									<bold>C</bold>) and (
									<bold>D</bold>) Western blot analysis of LC3, TIMM23, SQSTM1 and ACTB. (
									<bold>E</bold> and
									<bold>F</bold>) Autophagy was evaluated in the presence or absence of CQ with LPS or no LPS treatment for 4&#xA0;h. Western blot analysis of LC3, TIMM23, SQSTM1 and ACTB. Densitometric ratios were quantified using ImageJ software. LC3-II:ACTB and TIMM23:ACTB ratios from immunoblots are shown from 3 independent experiments. ACTB was used as the loading control.
								</p>
							</caption>
							<graphic content-type="color" xlink:href="kaup-15-03-1522467-g005"/>
						</fig>
					</p>
					<p>To confirm that
						<italic>Mir223</italic> inhibited autophagy-induced LC3 turnover and TIMM23 degradation, we performed similar autophagy assays in the presence or absence of the lysosomal inhibitor CQ. Indeed, addition of CQ led to the prominent accumulation of LC3-II and the degradation of TIMM23 in miR-CN-transfected cells upon LPS treatment, indicating the presence of normal autophagic flux under these conditions. However, because
						<italic>Mir223</italic> blocked autophagic vesicle generation, this inhibition-related accumulation of LC3-II and degradation of TIMM23 during LPS treatment was relatively decreased in BV2 cells overexpressing
						<italic>Mir223</italic> compared with mimic-expressing controls (
						<xref rid="F0005">Figure 5E</xref> and
						<xref rid="F0005">F</xref>).
					</p>
				</sec>
				<sec id="S0002-S2006">
					<title>
						<italic>Mir223</italic> blocked starvation-induced autophagy in BV2 cells
					</title>
					<p>To determine the role of
						<italic>Mir223</italic> in autophagy in microglia, we withdrew nutrition from BV2 cells transfected with
						<italic>Mir223</italic> mimics or mimic controls (Mim-CN) for 4&#xA0;h to assess changes in autophagy-related genes and proteins. As shown in Fig. S1A and S1B, overexpression of
						<italic>Mir223</italic> significantly blocked starvation-induced GFP-LC3 accumulation. In line with these results, in cell extracts, starvation-activated lipid conjugation of free LC3-I to the phagophore membrane to generate LC3-II was attenuated following transfection with
						<italic>Mir223</italic> mimics (Fig. S1C). Furthermore, degradation of the mitochondrial inner membrane protein TIMM23 following starvation was decreased in
						<italic>Mir223</italic>-transfected cell extracts (Fig. S1D). These results indicate that
						<italic>Mir223</italic> is a novel miRNA that controls autophagy.
					</p>
					<p>To confirm that
						<italic>Mir223</italic> inhibition of autophagy-induced LC3 turnover and TIMM23 degradation also inhibited autophagic vesicle flux, we performed similar autophagy assays in the presence or absence of CQ. Indeed, addition of CQ led to the prominent accumulation of LC3-II and degradation of TIMM23 in miR-CN-transfected cells, pointing to the presence of normal autophagic flux under these conditions. However, because
						<italic>Mir223</italic> blocked autophagic vesicle generation, inhibition-related accumulation of LC3-II and degradation of TIMM23 during starvation were relatively lower in BV2 cells overexpressing
						<italic>Mir223</italic> compared with mimic controls (Fig. S1E and S1F).
					</p>
				</sec>
				<sec id="S0002-S2007">
					<title>Inhibition of endogenous
						<italic>Mir223</italic> increases autophagy upon LPS stimulation
					</title>
					<p>We then tested whether endogenous
						<italic>Mir223</italic> inhibition also had an effect on LPS-induced autophagy. We observed that the formation of LPS-dependent GFP-LC3 puncta was significantly increased (
						<xref rid="F0006">Figure 6A</xref> and
						<xref rid="F0006">B</xref>). Furthermore LC3-I to LC3-II conversion was stimulated (
						<xref rid="F0006">Figure 6C</xref>), and therefore, autophagy was accelerated in cells transfected with
						<italic>Mir223</italic>-inhibiting constructs compared with control antagomirs. Moreover, TIMM23 was degraded following the inhibition of endogenous
						<italic>Mir223</italic> upon LPS stimulation compared with controls (
						<xref rid="F0006">Figure 6D</xref>). Therefore, inhibition of endogenous
						<italic>Mir223</italic> using antagomirs led to the further stimulation of autophagic activity during LPS stimulation, indicating that endogenous
						<italic>Mir223</italic> contributes to the limitation of the LPS-activated autophagic response in BV2 cells.
						<fig id="F0006" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0006</object-id>
							<label>Figure 6.</label>
							<caption>
								<p>Inhibition of endogenous
									<italic>Mir223</italic> increases autophagy upon LPS stimulation. (
									<bold>A</bold>)
									<italic>Mir223</italic> repressed the formation of starvation-induced GFP-LC3 puncta in BV2 cells. Stable GFP-LC3-expressing cells were cotransfected with inhibitor (In-
									<italic>Mir223</italic>) or In-CN, and autophagy was tested after LPS or control treatment for 4&#xA0;h. Scale bar: 5 &#x3BC;m. (
									<bold>B</bold>) Quantitative analysis of the number of GFP-LC3 puncta per cell in (
									<bold>A</bold>). The data are presented as the mean&#xB1;&#xA0;SEM; experiments were performed in triplicate (*
									<italic>p&#xA0;</italic>&lt;&#xA0;0.05, **
									<italic>p&#xA0;</italic>&lt;&#xA0;0.01). (
									<bold>C</bold> and
									<bold>D</bold>) Western blot analysis of LC3, TIMM23, SQSTM1 and ACTB. (
									<bold>E</bold> and
									<bold>F</bold>) Autophagy was tested in the presence or absence of CQ with LPS or control treatment for 4&#xA0;h. Western blot analysis of LC3, TIMM23, SQSTM1 and ACTB. Densitometric ratios were quantified using ImageJ software. LC3-II:ACTB and TIMM23:ACTB ratios from immunoblots are shown from 3 independent experiments. ACTB was used as the loading control.
								</p>
							</caption>
							<graphic content-type="color" xlink:href="kaup-15-03-1522467-g006"/>
						</fig>
					</p>
					<p>To confirm that inhibition of
						<italic>Mir223</italic> increased autophagy-induced LC3 turnover and TIMM23 degradation, we performed similar autophagy assays in the presence or absence of CQ. Consistent with the above results, accumulation of LC3-II and degradation of TIMM23 during LPS stimulation was relatively higher in BV2 cells transfected with
						<italic>Mir223</italic> inhibitor compared with cells transfected with inhibitor controls (
						<xref rid="F0006">Figure 6E</xref> and
						<xref rid="F0006">F</xref>). Hence, attenuation of autophagic activity through inhibition of
						<italic>Mir223</italic> led to increased GFP-LC3 accumulation in BV2 cells when endogenous
						<italic>Mir223</italic> was blocked.
					</p>
				</sec>
				<sec id="S0002-S2008">
					<title>Inhibition of endogenous
						<italic>Mir223</italic> increases autophagy upon starvation
					</title>
					<p>Antagomirs, or anti-miRNAs, counteract miRNA effects by specifically inhibiting endogenous mature miRNAs. To test the effects of endogenous
						<italic>Mir223</italic> inhibition on autophagy, we transfected cells with
						<italic>Mir223</italic>-specific antagomirs (Inhibitor) or control antagomirs (In-CN) and analyzed autophagy under conditions of starvation or no starvation. We observed that the starvation-dependent formation of GFP-LC3 puncta was modestly but significantly increased (Fig. S2A and S2B) and LC3-I to LC3-II conversion was stimulated (Fig. S2C). Hence, autophagy was accelerated in cells transfected with
						<italic>Mir223</italic> inhibitor but not with control antagomirs. Moreover, TIMM23 degradation following starvation was more prominent after inhibition of
						<italic>Mir223</italic> compared with inhibitor controls (Fig. S2D). Therefore, inhibition of endogenous
						<italic>Mir223</italic> using antagomirs led to the further stimulation of autophagic activity during starvation, indicating that endogenous
						<italic>Mir223</italic> contributes to the limitation of stress-activated autophagic responses in microglial cells.
					</p>
					<p>To confirm that inhibition of
						<italic>Mir223</italic> increased autophagy-induced LC3 turnover and TIMM23 degradation, we performed similar autophagy assays in the presence or absence of CQ. However, because inhibition of
						<italic>Mir223</italic> improved autophagic vesicle generation, accumulation of LC3-II and degradation of TIMM23 during starvation was relatively higher in BV2 cells transfected with
						<italic>Mir223</italic> inhibitor compared with those transfected with inhibitor controls (Fig. S2E and S2F). Hence, attenuation of autophagic activity through
						<italic>Mir223</italic> inhibition led to increased GFP-LC3 accumulation in BV2 cells in which endogenous
						<italic>Mir223</italic> was blocked.
					</p>
				</sec>
				<sec id="S0002-S2009">
					<title>The autophagy-related
						<italic>Atg16l1</italic> gene is a direct target of
						<italic>Mir223</italic>
					</title>
					<p>To determine the mechanism of
						<italic>Mir223</italic>-mediated autophagy inhibition, we searched for autophagy-related genes containing potential
						<italic>Mir223</italic> response elements in their 3&#x2019; UTRs using the publicly available bioinformatics tools microRNA and miRTarBase.
						<italic>Atg16l1</italic> (GenBank accession number: NM_001205391.1, 138&#x2013;163) was identified as a
						<italic>Mir223</italic> target by both bioinformatics tools. The predicted interaction between
						<italic>Mir223</italic> and the
						<italic>Atg16l1</italic> 3&#x2019; UTR is shown in
						<xref rid="F0007">Figure 7A</xref>.
						<fig id="F0007" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0007</object-id>
							<label>Figure 7.</label>
							<caption>
								<p>
									<italic>Atg16l1</italic> as a direct target of
									<italic>Mir223</italic>. (
									<bold>A</bold>) The
									<italic>Mir223</italic> target sequence in the 3&#x2019; UTR of
									<italic>Atg16l1</italic> in mice. (
									<bold>B</bold>) A scheme representing the luciferase constructs with the wild-type (WT) or mutant 3&#x2019; UTR
									<italic>Mir223</italic> MRE sequences of
									<italic>Atg16l1</italic>. Mutations are marked in lower-case letters and underlined. (
									<bold>C</bold>) Normalized luciferase activity in lysates from 293T cells co-transfected with wild-type or mutant
									<italic>Atg16l1</italic>-luciferase constructs and
									<italic>Mir223</italic> mimics or Mim-CN (mean&#xB1;&#xA0;SEM, n&#xA0;=&#xA0;3, *
									<italic>p&#xA0;</italic>&lt;&#xA0;0.05, **
									<italic>p&#xA0;</italic>&lt;&#xA0;0.01). (
									<bold>D</bold> and
									<bold>E</bold>) BV2 cells were cotransfected with
									<italic>Mir223</italic> Mim-CN, mimics, In-CN or inhibitor and starved for 4&#xA0;h. Quantitative PCR (qPCR) analysis of
									<italic>Atg16l1</italic> mRNA levels is shown. (
									<bold>F</bold> and
									<bold>G</bold>) BV2 cells were cotransfected with
									<italic>Mir223</italic> Mim-CN, mimics, In-CN or inhibitor and starved for 4&#xA0;h. The ATG16L1 protein level was tested by immunoblotting. ACTB was used as the loading control. (
									<bold>H</bold>) Quantitative PCR (qPCR) analysis of
									<italic>Atg16l1</italic> mRNA levels in In-CN- or inhibitor-transfected BV2 cells. The data are expressed as the mean&#xB1;&#xA0;SEM; experiments were performed in triplicate (*
									<italic>p&#xA0;</italic>&lt;&#xA0;0.05, **
									<italic>p&#xA0;</italic>&lt;&#xA0;0.01). The data were normalized to
									<italic>Gapdh</italic> mRNA.
								</p>
							</caption>
							<graphic content-type="black-white" xlink:href="kaup-15-03-1522467-g007"/>
						</fig>
					</p>
					<p>To further validate the effect of
						<italic>Mir223</italic> on
						<italic>Atg16l1</italic>, the region in the 3&#x2019; UTR of the
						<italic>Atg16l1</italic>&#xA0;mRNA containing a potential
						<italic>Mir223</italic> response element was cloned into the 3&#x2019; UTR of a luciferase vector. In parallel, we also created a mutant version of this construct by introducing base changes to the crucial binding residues, primarily in the
						<italic>Mir223</italic> seed sequence-binding region (
						<xref rid="F0007">Figure 7B</xref>). Cotransfection of
						<italic>Mir223</italic> mimics together with the wild-type luciferase vector in 293T cells resulted in a significant decrease in luciferase activity compared with control levels (
						<xref rid="F0007">Figure 7C</xref>, target). In contrast,
						<italic>Mir223</italic> had no significant effect on the levels of luciferase activity compared to the mutant construct; here, the luciferase activity was similar to control levels (
						<xref rid="F0007">Figure 7C</xref>, mutant). These results showed that
						<italic>Mir223</italic> controlled the levels of ATG16L1 by directly targeting the above-described MRE in the 3&#x2019; UTR region of the
						<italic>Atg16l1</italic> gene.
					</p>
					<p>The expression of
						<italic>Mir223</italic> was decreased by qPCR in BV2 cells following transfection with
						<italic>Mir223</italic> inhibitor but not with In-CN in the presence or absence of LPS stimulation (
						<xref rid="F0007">Figure 7E</xref>). To confirm the bioinformatics-based predictions, we performed immunoblot assays of control- or
						<italic>Mir223</italic> mimic-transfected cell extracts using an ATG16L1-specific antibody. Indeed, ATG16L1 protein levels were decreased in BV2 cells overexpressing
						<italic>Mir223</italic> under starvation conditions (
						<xref rid="F0007">Figure 7F</xref>). Conversely, introduction of the
						<italic>Mir223</italic> antagomir, but not control antagomirs, resulted in an increase in ATG16L1 protein levels in BV2 cells during starvation (
						<xref rid="F0007">Figure 7G</xref>).
						<italic>Mir223</italic> expression also affected target transcript levels in cells. An increase in
						<italic>Atg16l1</italic> mRNA levels was observed by qPCR in BV2 cells following transfection with
						<italic>Mir223</italic> inhibitor but not with In-CN (
						<xref rid="F0007">Figure 7H</xref>).
					</p>
				</sec>
				<sec id="S0002-S2010">
					<title>Overexpression of ATG16L1 abrogated
						<italic>mir223</italic>-mediated suppression of autophagy
					</title>
					<p>To further confirm that downregulation of ATG16L1 was responsible for the autophagy-related effects of
						<italic>Mir223</italic>, we performed &#x2018;rescue experiments&#x2019;. In these experiments,
						<italic>Atg16l1</italic> was overexpressed by a plasmid lacking a
						<italic>Mir223</italic> binding site; it was therefore resistant to
						<italic>Mir223</italic>-mediated downregulation of
						<italic>Atg16l1</italic>. Hence, although
						<italic>Mir223</italic> overexpression decreased endogenous ATG16L1 protein levels significantly, cells cotransfected with the
						<italic>Mir223</italic> mimics and an
						<italic>Atg16l1</italic> plasmid lacking the
						<italic>Mir223</italic> binding site possessed near-physiological levels of total ATG16L1 protein (
						<xref rid="F0008">Figure 8A</xref> and
						<xref rid="F0008">B</xref>). Under these conditions, the
						<italic>Mir223</italic>-mediated suppression of autophagy observed during starvation-induced autophagy was reversed upon co-expression of the ATG16L1 protein (
						<xref rid="F0008">Figure 8C</xref> and
						<xref rid="F0008">D</xref>). In other words, introduction of the ATG16L1 protein was sufficient to return autophagy back to normal levels even in the presence of the
						<italic>Mir223</italic> mimics. These results demonstrated that
						<italic>Atg16l1</italic> was the target of
						<italic>Mir223</italic> for the suppression of autophagy.
						<fig id="F0008" fig-type="figure" orientation="portrait" position="float">
							<object-id pub-id-type="doi">10.1080/15548627.2018.1522467-F0008</object-id>
							<label>Figure 8.</label>
							<caption>
								<p>ATG16L1 protein overexpression abrogates
									<italic>Mir223</italic>-mediated autophagy suppression. BV2 cells were cotransfected with
									<italic>Mir223</italic> mimics or Mim-CN and ATG16L1 expression plasmid lacking the
									<italic>Mir223</italic> target region. (
									<bold>A</bold>) Cells were starved for 4&#xA0;h. Immunoblot analysis of ATG16L1 and ACTB is shown. (
									<bold>B</bold>) ATG16L1:ACTB ratios. (
									<bold>C</bold>) Formation of GFP-LC3 puncta before or after starvation for 4&#xA0;h. Scale bar: 5 &#x3BC;m. (
									<bold>D</bold>) Quantitative analysis of GFP-LC3 puncta (mean&#xB1;&#xA0;SEM, n&#xA0;=&#xA0;3, *
									<italic>p&#xA0;</italic>&lt;&#xA0;0.05, **
									<italic>p&#xA0;</italic>&lt;&#xA0;0.01). (
									<bold>E</bold>) Model of the effect of
									<italic>Mir223</italic> regulation of autophagy through direct targeting of
									<italic>Atg16l1.</italic>
								</p>
							</caption>
							<graphic content-type="color" xlink:href="kaup-15-03-1522467-g008"/>
						</fig>
					</p>
				</sec>
				<sec id="S0002-S2011">
					<title>
						<italic>Mir223</italic> regulation of autophagy is independent of the BCL2 and PPARG pathways
					</title>
					<p>The antiapoptotic protein BCL2 is involved in autophagy regulation through sequestration of the autophagy-related protein BECN1. In our study, inhibition or overexpression of
						<italic>Mir223</italic> did not significantly affect the levels of BCL2 protein under LPS stimulation conditions in BV2 cells (Fig. S3A and S3B). Therefore, we propose that autophagy regulation by
						<italic>Mir223</italic> did not proceed through BCL2. We also examined whether there are other autophagy-related targets of
						<italic>Mir223</italic>. Because
						<italic>Mir223</italic> can regulate IFNG (interferon gamma) by directly targeting PPARG (peroxisome proliferator activated receptor gamma), and PPARG plays an important role in the activation of macrophage cells and in neuronal autophagy during cerebral ischemia-reperfusion injury[
						<xref rid="CIT0041">41</xref>], we wondered whether the PPARG pathway would be affected by
						<italic>Mir223</italic> overexpression. To assess the effect of
						<italic>Mir223</italic> on PPARG, we analyzed the protein levels of PPARG. Although under basal/fed conditions, inhibition or overexpression of
						<italic>Mir223</italic> did not have a differential effect on PPARG expression between cells transfected with
						<italic>Mir223</italic> inhibitor or mimics and control cells, PPARG expression vanished following autophagy activation via LPS stimulation (Fig. S4). Therefore, we concluded that although it is possible that other targets of
						<italic>Mir223</italic> could contribute to its biological effects, ATG16L1 appears to be the major and rate-limiting autophagy-related target of
						<italic>Mir223</italic>.
					</p>
				</sec>
			</sec>
			<sec id="S0003">
				<title>Discussion</title>
				<p>In this study, we introduced
					<italic>Mir223</italic> as a novel autophagy regulator.
					<italic>Mir223</italic> deficiency significantly reduced the severity of neurobehavioral deficits, cumulative scores, and maximum neurological disability in EAE mice compared with WT mice. The effect of
					<italic>Mir223</italic> was abolished by the autophagy inhibitor 3-MA, suggesting that
					<italic>Mir223</italic> plays a role in EAE progression at least partly through autophagy. Here, we found
					<italic>mir223</italic>
					<sup>&#x2212;/-</sup> reduced the number of active microglia and macrophages and simultaneously increased the number of resting microglia. Moreover, there were considerably higher levels of LC3 protein in microglia in the brains of
					<italic>mir223</italic>
					<sup>&#x2212;/-</sup> mice than in wild-type controls during the acute phase of EAE. Overexpression of
					<italic>Mir223</italic> inhibited GFP-LC3 accumulation, LC3-I to LC3-II conversion and TIMM23 degradation in BV2 cells. These results were validated by stimulation of BV2 cell autophagy upon starvation and LPS treatment. Additionally, antagonist-mediated suppression of endogenous cellular
					<italic>Mir223</italic> accelerated the autophagic response. Together, these data showed that
					<italic>Mir223</italic> is a key player in controlling autophagy. We identified ATG16L1 as a target of
					<italic>Mir223</italic> through miRNA gene blast and luciferase reporter analysis of the MRE found in the 3&#x2019; UTR region of the
					<italic>Atg16l1</italic> gene. The results we obtained in this study may be summarized in a mechanistic model as follows (
					<xref rid="F0008">Figure 8E</xref>): A certain portion of cellular ATG16L1 protein can form functional ATG12&#x2013;ATG5-ATG16L1 complexes, followed by LC3 lipidation and autophagy activation. The presence of
					<italic>Mir223</italic> under stimulation leads to the downregulation of ATG16L1 protein levels below the threshold and therefore results in a decrease in LC3 lipidation and inhibition of autophagic activity. Thus, inhibiting
					<italic>Mir223</italic> can regulate autophagy and improve/limit uncontrolled or potentially harmful autophagic activity in cells.
				</p>
				<p>An increasing number of studies have revealed novel knowledge regarding autophagy, and our understanding of autophagy in autoimmune inflammation is rapidly being updated. It is principally thought that autophagy plays an important role in protecting neurocytes from inflammation. BCL2 and BECN1 are important for controlling cellular autophagy in response to environmental stress or treatment with BH3 peptidomimetics. In this study, we found that
					<italic>Mir223</italic> did not affect BCL2 and BECN1 expression during EAE progression or in BV2 cells upon LPS stimulation. These results suggested that
					<italic>Mir223</italic> regulates autophagy through other pathways.
				</p>
				<p>Multiple genetic studies have implicated the autophagy-related gene
					<italic>Atg16l1</italic> in this regulatory process, and luciferase reporter assays have indicated that
					<italic>MIR106B</italic> and
					<italic>MIR93</italic> target
					<italic>ATG16L1</italic> mRNA [
					<xref rid="CIT0042">42</xref>]. Zhai et al. reported miRNA-mediated regulation of ATG16L1 in colonic epithelial cells as well as Jurkat T cells. Dual-luciferase reporter assays found that
					<italic>MIR142</italic> is a key miRNA that regulates
					<italic>ATG16L1</italic> by targeting the 3&#x2019; UTR. The study revealed that
					<italic>MIR142</italic> is a new autophagy-regulating small molecule that acts by targeting
					<italic>ATG16L1</italic>, indicating a role of
					<italic>MIR142</italic> in intestinal inflammation and Crohn disease[
					<xref rid="CIT0043">43</xref>]. Other researchers have found that ATG16L1 is also a target gene regulated by
					<italic>Mir20a</italic> [
					<xref rid="CIT0044">44</xref>,
					<xref rid="CIT0045">45</xref>]. Bacillus Calmette-Gu&#xE9;rin infection of macrophages results in enhanced expression of
					<italic>Mir20a</italic>, which decreases the expression levels of LC3-II and the number of LC3 puncta in macrophages. In addition,
					<italic>Mir20a</italic> promotes Bacillus Calmette-Gu&#xE9;rin survival in macrophages, whereas transfection with a
					<italic>Mir20a</italic> inhibitor has the opposite effect. Moreover, transfection with a
					<italic>Mir20a</italic> mimic leads to a significant reduction in the number of autophagosomes per cellular cross-section, but transfection with a
					<italic>Mir20a</italic> inhibitor increases the number of autophagosomes per cellular cross-section [
					<xref rid="CIT0046">46</xref>]. In ischemic kidney injury and HK-2 cells under hypoxic conditions, the expression of punctate LC3 and ATG16L1 is increased and
					<italic>Mir20a</italic> expression is decreased. The 3&#x2019; UTR luciferase reporter assays indicate that
					<italic>Mir20a</italic> targets
					<italic>Atg16l1</italic> mRNA. Overexpression of
					<italic>Mir20a</italic> and antagoMir20a also confirm these results [
					<xref rid="CIT0044">44</xref>]. In osteoclasts, a dual-luciferase reporter assay revealed that
					<italic>Mir20a</italic> directly targets
					<italic>Atg16l1</italic> by binding to its 3&#x2019; UTR [
					<xref rid="CIT0045">45</xref>].
				</p>
				<p>We identified ATG16L1 as a target of
					<italic>Mir223</italic> through miRNA gene blast and luciferase reporter analysis of the MRE found in the 3&#x2019; UTR region of the
					<italic>Atg16l1</italic> gene, and we found that introduction of mutations to this sequence abolished the effect of
					<italic>Mir223</italic>. We showed that
					<italic>Mir223</italic> overexpression attenuated ATG16L1 protein and mRNA levels, and more importantly, reintroduction of ATG16L1 protein in the presence of
					<italic>Mir223</italic> mimics blocked autophagy. Therefore, our results established ATG16L1 as an important target of
					<italic>Mir223</italic> during autophagy regulation. Whether autophagy inhibits or enhances inflammatory cell infiltration depends on the related signaling pathways targeted by different stimulators and cells. Moreover, further studies are needed to reveal the role of autophagy during autoimmune inflammatory reactions.
				</p>
				<p>
					<italic>Mir223</italic> was previously shown to be involved in various biological processes, such as development, differentiation, hematopoiesis, and immune modulation. In fact, autophagy has also been described as an important regulator of similar physiological events [
					<xref rid="CIT0047">47</xref>&#x2013;
					<xref rid="CIT0050">50</xref>]. Study of the effects of autophagy on these processes could provide valuable information about the importance of
					<italic>Mir223. Mir223</italic> was upregulated in the blood and lung parenchyma of tuberculosis (TB) patients and in TB-infected mice. Deletion of
					<italic>Mir223</italic> renders TB-resistant mice highly susceptible to acute lung infection [
					<xref rid="CIT0051">51</xref>]. The apoptosis rate of peripheral blood macrophages is decreased in active TB patients compared with healthy controls. Transfection of human macrophages (TDMs and MDMs) with
					<italic>MIR223</italic> inhibits macrophage apoptosis. Moreover, researchers found that
					<italic>MIR223</italic> directly suppresses FOXO3 (forkhead box O3), and FOXO3 plays a critical role as a mediator of the biological effects of
					<italic>MIR223</italic> in macrophage apoptosis [
					<xref rid="CIT0052">52</xref>]. In macrophages,
					<italic>MIR223</italic> may regulate apoptosis by directly targeting
					<italic>FOXO3</italic>. Activation of CNR2 (cannabinoid receptor 2, [macrophage]) can ameliorate the pathogenesis of EAE, whereas deleting
					<italic>Cnr2</italic> decreases LC3-II/LC3-I and BECN1 expression and increases CASP1 (caspase 1) activation and IL1B production in EAE mice. In contrast activation of CNR2 with the specific agonist HU-308 induces inverse effects. At the same time, one study reported that HU-308 promotes autophagy in BV2 microglia. These results demonstrate that CNR2 plays a protective role in EAE by promoting autophagy [
					<xref rid="CIT0053">53</xref>]. In our results, we also found that
					<italic>Mir223</italic> expression was increased in the spleen and CNS during EAE progression (unpublished data). At the same time, autophagy was repressed in brain microglial cells, whereas
					<italic>Mir223</italic> deficiency increased LC3 expression and ameliorated EAE pathogenesis.
				</p>
				<p>Some researchers have identified an increase in autophagy during the progression of autoimmune disease. Systemic lupus erythematosus is an autoimmune disease, and overexpression of TLR7 has been found to be associated with this disease. We ablated autophagy in
					<italic>Tlr7</italic>-transgenic (Tg) mice, and, in the absence of autophagy, these mice were cured of lupus. This was also supported by the survival of autophagy-deficient mice compared to the Tg(Tlr7)1Boll/Tlr7.1 Tg mice [
					<xref rid="CIT0054">54</xref>]. Rheumatoid arthritis (RA) is a kind of autoimmune disease that involves dysregulation of CD4
					<sup>+</sup> T cells. One report demonstrated that autophagy is significantly increased in CD4
					<sup>+</sup> T cells from RA patients and that increased autophagy is also observed in activated CD4
					<sup>+</sup> T cells. Increased resistance to apoptosis is also observed in CD4
					<sup>+</sup> T cells from RA patients. These results provide novel insight into the connection between the pathogenesis of RA and autophagy [
					<xref rid="CIT0055">55</xref>].
				</p>
				<p>Autophagy deficiency is associated with many diseases. Therefore, autophagy has been proposed as a cell-protective mechanism. Similarly, we observed that inhibition of
					<italic>Mir223</italic> can ameliorate the pathogenesis of EAE by increasing autophagy in brain microglial cells. Further research also showed that intraperitoneal injection of 3-MA in mice can aggravate the pathogenesis of EAE. Therefore, changes in the
					<italic>Mir223</italic> level might modulate autophagy and affect the clinical pathogenesis of EAE. Further studies are required to explore the contribution of
					<italic>Mir223</italic> expression to other autoimmune diseases regulated by macrophages.
				</p>
			</sec>
			<sec id="S0004">
				<title>Materials and methods</title>
				<sec id="S0004-S2001">
					<title>Animal experiments</title>
					<p>Female C57BL/6 mice aged 7&#x2013;8&#xA0;weeks were purchased from the Academy of Military Medical Science (Beijing, China).
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice were kindly provided by Fei Gao&#x2019;s lab (Institute of Zoology, Chinese Academy of Sciences, Beijing), which is a global knockout. The
						<italic>Mir223</italic> gene is located on the X chromosome. The animals were housed and fed in a specific pathogen-free animal facility at the Experimental Animal Center of Tianjin Medical University (Tianjin, China). The experiments were performed in accordance with the guidelines for animal care and were approved by the Animal Ethics Committee of Tianjin Medical University (Tianjin, China).
					</p>
					<p>For EAE induction, the C57BL/6 female mice were immunized (subcutaneously) with 200&#xA0;&#xB5;g of myelin oligodendrocyte glycoprotein (MOG residues 35&#x2013;55). The peptide sequence was Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-ArgVal-Val-His-Leu-Tyr-Arg- Asn-Gly-Lys, and the purity was &gt;&#xA0;95% (CL Bio-Scientific Co., Ltd.). The immunization was performed by mixing the MOG[
						<xref rid="CIT0035">35</xref>&#x2013;
						<xref rid="CIT0055">55</xref>] peptide with complete Freund&#x2019;s adjuvant containing 500&#xA0;&#xB5;g of heat-killed H37Ra, a
						<italic>Mycobacterium tuberculosis</italic> strain (Difco Laboratories, 231,141). Pertussis toxin (200 ng) (List Biological Laboratories, 180) in PBS (BBI Life Sciences, A610100-0001) was administered intraperitoneally on the day of immunization and again after 48&#xA0;h. For inhibition of autophagy, mice were treated with 3-MA (10&#xA0;mg/kg; Sigma, M9281) daily. The mice were weighed and examined daily for disease symptoms, which were assessed using the following standard score system: 0, no obvious changes in motor functions; 1.0, limp tail; 2.0, limp tail and wobbly gait; 3.0, bilateral hind limb paralysis; 4.0, complete hind limb and partial forelimb paralysis; and 5.0, death [
						<xref rid="CIT0056">56</xref>].
					</p>
				</sec>
				<sec id="S0004-S2002">
					<title>Histopathology and immunohistochemistry</title>
					<p>The lumbar spinal cords from the female C57BL/6 mice and
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice (n&#xA0;=&#xA0;6) were perfused transcardially with 4% (weight:volume) paraformaldehyde and were then dissected and post-fixed for 48&#xA0;h. The spinal cord paraffin sections (7 &#x3BC;m) were stained with H&amp;E to detect inflammatory cell infiltration and with luxol fast blue (Alfa Aesar,1328&#x2013;51-4) to assess demyelination.
					</p>
					<p>The brains from the wild-type C57BL/6 mice and
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice (n&#xA0;=&#xA0;6) were perfused transcardially with 4% (weight:volume) paraformaldehyde and then were dissected and post-fixed for 48&#xA0;h. The brain paraffin sections (7 &#x3BC;m) were stained with DAPI (Thermo Fisher Scientific, 00&#x2013;4959-52), LC3A/B (Cell Signaling Technology, 12,741), BCL2 (Abcam, ab32124), BECN1 (Cell Signaling Technology, 3495), AIF1/IBA1 (allograft inflammatory factor 1) (Abcam, ab107159) and Alexa Fluor 488 (Proteintech, SA00006-2) and Alexa Fluor 546 (Thermo Fisher Scientific, A11056) secondary antibody conjugates (green and red, respectively).
					</p>
				</sec>
				<sec id="S0004-S2003">
					<title>Intracellular cytokine staining</title>
					<p>The single-cell suspensions were isolated from the brain and spinal cords of WT or
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> EAE mice by grinding and filtering the tissue through a cell strainer. Then, the macrophages and microglial cells were separated by Percoll (GE Healthcare Bio-Sciences AB, 17&#x2013;0891-09) gradient centrifugation at 630g for 25&#xA0;min. The cell surface markers were assessed with APC-conjugated anti-mouse PTPRC antibody (eBioscience, 17&#x2013;0451-82) and PE-conjugated anti-mouse ITGAM (eBioscience, 12&#x2013;0112-82). Nonspecific staining was monitored with isotype antibody controls PE IgG2b (eBioscience, 12&#x2013;4031-82) and APC IgG2b (Sungene biotech, R20022-11A). The cells were analyzed by BD FACS Canto II (BD Biosciences, USA), and the acquired data were analyzed using FlowJo software.
					</p>
				</sec>
				<sec id="S0004-S2004">
					<title>Separation of macrophages from bone marrow</title>
					<p>Femurs and tibias, removed from wild-type C57BL/6 mice and
						<italic>mir223</italic>
						<sup>&#x2212;/-</sup> mice immediately after they were sacrificed, were cleaned of muscle tissues, placed in a petri dish with 70% ethanol for 2&#x2013;3&#xA0;min and washed twice in sterile culture medium. Bone ends were cut, and the marrow was flushed out into a new petri dish with 10&#xA0;ml of RPMI (Gibco, 31,800&#x2013;022). Cells were then washed and resuspended in RPMI supplemented with 10% fetal bovine serum (FBS; Gibco, 10,099,141) and 10&#xA0;ng/ml CSF1/M-CSF (Peprotech, 315&#x2013;02). After an adhesion step of 5&#xA0;days on a plastic dish at 37&#xB0;C and 5% CO
						<sub>2</sub>, the cells were stimulated with LPS (Sigma, L4516) or starvation for 4&#xA0;h.
					</p>
				</sec>
				<sec id="S0004-S2005">
					<title>Cell culture and treatment</title>
					<p>The mouse microglial cell line BV2 was obtained from the Cell Resource Center, IBMS, CAMS/PUMC (Beijing, China). The cell line was grown in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (Gibco, 12,800&#x2013;017), supplemented with 10% FBS, and 10&#xA0;U/ml penicillin-streptomycin (Gibco, 15,140&#x2013;122). The cells were cultured in a 5% CO
						<sub>2</sub> humidified incubator at 37&#xB0;C. LPS and hydroxychloroquine (CQ; Sigma, H0915) were dissolved in DMEM and dimethyl sulfoxide (Solarbio, D8370), separately. To induce autophagy, cells were treated with starvation or LPS for 4&#xA0;h.
					</p>
				</sec>
				<sec id="S0004-S2006">
					<title>Transmission electron microscopy</title>
					<p>The cells were fixed with ice cold 2.5% glutaraldehyde (pH 7.4). After being washed 3 times with 0.1&#xA0;M phosphate buffer, pH 7.4, the cells were fixed with 1% osmium tetraoxide for 1&#xA0;h. The samples were dehydrated in a graded series of ethanol concentrations and embedded in Spurr resin (TED PELLA, 18,300&#x2013;4221). The ultrathin sections were cut to a thickness of 70&#xA0;nm and then double-stained with uranyl acetate and lead citrate. The number of autophagic vacuoles was determined for a minimum of 100 cells. The samples were examined and photographed with a JEM-1230 transmission electron microscope (JEOL, Japan) by FCEN Company (Shanghai Fucheng Biological Technology Co., Ltd., China).</p>
				</sec>
				<sec id="S0004-S2007">
					<title>Target prediction for miRNA</title>
					<p>miRNA targets were identified using the publicly available bioinformatics tools microRNA (
						<ext-link ext-link-type="uri" xlink:href="http://www.microrna.org/microrna/home.do">http://www.microrna.org/microrna/home.do</ext-link>) and miRTarBase (
						<ext-link ext-link-type="uri" xlink:href="http://mirtarbase.mbc.nctu.edu.tw/">http://mirtarbase.mbc.nctu.edu.tw/</ext-link>).
					</p>
				</sec>
				<sec id="S0004-S2008">
					<title>MicroRNA, siRNA, plasmid and transfection</title>
					<p>
						<italic>Mir223</italic> mimics, control mimics (Mim-CN),
						<italic>Mir223</italic> inhibitor (a
						<italic>Mir223</italic>-specific antagomir), and control inhibitor (In-CN) were synthesized by Ribobio (Guangzhou, China). For the dual-luciferase assay, the MRE found in the 3&#x2019; UTR region of the
						<italic>Atg16l1</italic> mRNA and its mutated version were cloned into a pmirGLO-control vector (Promega, E1741) at the 3&#x2019; region of the luciferase gene using the following linker primers:
						<italic>Atg16l1</italic> wild-type primers. 5&#x2019;-CGTAGCGGCCGCTAGTTGGGGAGTACAGGGTCCCT-3&#x2019; and 5&#x2019;-CTAGAGGGACCCTGTACTCCCCAACTAGCGGCCGCTACGAGCT-3&#x2019; and
						<italic>Atg16l1</italic> mutant primers 5&#x2019;-CTAGAGGGACCCTGTACTCCCCAACTAGCGGCCGCTACGAGCT-3&#x2019; and 5&#x2019;-CTAGAGGGTGGGAGTACTCCCCAACTAGCGGCCGCTACGAGCT-3&#x2019;.
					</p>
					<p>Transient transfection of BV2 cells was performed using either polyethyleneimine (Polysciences Inc., 23,966) or Lipofectamine&#xAE; RNAi Max reagent (Invitrogen, 13,778&#x2013;075) according to the manufacturer&#x2019;s instructions. Briefly, 293T cells were harvested and lysed 48&#xA0;h post-transfection. Firefly and Renilla luciferase activities were measured using a dual-luciferase-reporter assay system (Promega, E1910). The results were evaluated through normalization of the firefly luciferase activity with the Renilla luciferase activity.</p>
				</sec>
				<sec id="S0004-S2009">
					<title>GFP-LC3 analyses</title>
					<p>Forty-eight h after cotransfection of
						<italic>Mir223</italic> mimics, Mim-CN, inhibitor, In-CN and GFP-LC3 (HANBio, China), BV2 cells were incubated for 4&#xA0;h in EBSS medium or in DMEM-FBS containing 500&#xA0;ng/ml LPS for 4&#xA0;h. Cells were fixed in 4% formaldehyde for 10&#xA0;min, washed with PBS, mounted and inspected under 100 &#xD7;&#xA0;magnification using a BX60 fluorescence microscope (Olympus, Germany), followed by image analysis with ImageJ software (National Institutes of Health, Bethesda, MD, USA) after quantifying pixel (200 pixels) intensities of both cellular compartments and subtracting background fluorescence. At least 100 GFP-positive cells per condition were counted, and the graphs were plotted as the number of GFP-LC3 puncta per cell.
					</p>
				</sec>
				<sec id="S0004-S2010">
					<title>Western blot analyses and antibodies</title>
					<p>Protein extraction was performed with RIPA buffer supplemented with complete protease inhibitor cocktail (Roche, 04&#x2013;693-131&#x2013;001) and 1&#xA0;mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, P7626). The lysates were clarified by centrifugation at 3600&#xA0;g for 20&#xA0;min at 4&#xB0;C, and the protein concentration was quantified using the BCA protein assay kit (Applygen Technologies Inc., P1511). Cell extracts (5&#x2013;10 &#x3BC;g) were denatured for 5&#xA0;min in 5 &#xD7;&#xA0;SDS-PAGE loading buffer (CWBIO, cw0027), separated on 10% SDS-polyacrylamide gels and transferred onto PVDF membranes (Roche, 03010040001). Following blocking in 5% nonfat milk in TBST (20&#xA0;mM Tris base, 137&#xA0;mM NaCl, 0.1% Tween 20 [SbaseBio, A336], pH 7.4) for 1&#xA0;h at room temperature, membranes were incubated in 5% milk-TBST solutions containing the following primary antibodies: anti-ATG16L1 (Cell Signaling Technology, 8089), anti-LC3 (Cell Signaling Technology, 12,741), anti-SQSTM1/p62 (Cell Signaling Technology, 5114), anti-TIMM23 (Proteintech, 11,123&#x2013;1-AP), anti-ACTB/&#x3B2;-actin (Vazyme, Ab101-01), anti-BCL2 (Abcam, ab32124) and anti-PPARG (Proteintech, 22,061&#x2013;1-AP) at 4&#xB0;C overnight. Then, secondary anti-mouse or anti-rabbit antibodies coupled to horseradish peroxidase (anti-mouse Tianjin Sungene Biotech Co., Ltd., LK2002; anti-rabbit Tianjin Sungene Biotech Co., Ltd., LK2001) were applied in 5% milk-TBST for 1&#xA0;h at room temperature, and protein bands were revealed with chemiluminescence HRP substrate (Millipore, WBKLS0500). Protein loading volume and strip exposure time for every antibody were detected before the formal experiment. Band intensities were quantified using ImageJ software.</p>
				</sec>
				<sec id="S0004-S2011">
					<title>RNA isolation and RT-PCR analyses</title>
					<p>Total RNA was extracted using TRIzol reagent (Invitrogen, 15,596&#x2013;026) according to the manufacturer&#x2019;s instructions. cDNA was reverse transcribed from total RNA (DNase treated) using M-MLV reverse transcriptase (Invitrogen, 28,025&#x2013;013) and random hexamers (Invitrogen, 48,190&#x2013;011).</p>
				</sec>
				<sec id="S0004-S2012">
					<title>Real-time-Pcr for Mir223 and Atg16l1 mRNA quantification</title>
					<p>A SYBR Green Quantitative RT-PCR kit (Roche, 04&#x2013;913,914-001) was used for single-step qRT-PCR reactions. To activate the SYBR green, an initial cycle of 95&#xB0;C for 10&#xA0;min was performed, followed by PCR reactions with 40 cycles of 95&#xB0;C for 15 sec and 60&#xB0;C for 1&#xA0;min. Then, a thermal denaturation protocol was used to generate the dissociation curves to verify the amplification specificity (a single cycle of 95&#xB0;C for 60 sec, 55&#xB0;C for 60 sec and 80 cycles of 55&#xB0;C for 10 sec). Changes in mRNA levels were quantified using the 2-&#x394;&#x394;CT method with
						<italic>Gapdh</italic> (glyceraldehyde-3-phosphate dehydrogenase) mRNA as a control. The following primers were used:
						<italic>Atg16l1</italic> primers, 5&#x2019;-CAGAGCAGCTACTAAGCGACT-3&#x2019; and 5&#x2019;-AAAAGGGGAGATTCGGACAGA-3&#x2019;;
						<italic>Gapdh</italic> primers, 5&#x2019;-AGCCACATCGCTCAGACAC-3&#x2019; and 5&#x2019;-GCCCAATACGACCAAATCC-3&#x2019;;
						<italic>Rnu6</italic> primers, 5&#x2019;-CTCGCTTCGGCAGCACA-3&#x2019; and 5&#x2019;-AACGCTTCACGAATTTGCGT;
						<italic>Mir223</italic> RT primers, 5&#x2019;-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGTGGGGTA-3&#x2019; and
						<italic>Mir223</italic> primers, 5&#x2019;-GCCCGfCCAGUUUGUCAAAUA-3&#x2019; and 5&#x2019;-GTGCAGGGTCCGAGGT-3&#x2019;. Reactions were performed in duplicates and the number of independent experiments (n&#xA0;=&#xA0;3) was indicated. The reactions were performed with a 7500 Fast Real-Time PCR System (Applied Biosystems, USA).
					</p>
				</sec>
				<sec id="S0004-S2013">
					<title>Statistical analyses</title>
					<p>Statistical analyses were performed using Student&#x2019;s two-tailed t-test or ANOVA. Data were analyzed using Microsoft office Excel 2010 or SPSS Statistics 15 and presented as the mean&#xB1;&#xA0;SEM using the GraphPad Prism statistical program. Values of
						<italic>p&#xA0;</italic>&lt;&#xA0;0.05 were considered significant. No potential conflicts of interest were disclosed.
					</p>
				</sec>
			</sec>
		</body>
		<back>
			<sec id="S0005">
				<title>Disclosure statement</title>
				<p>The authors have no financial conflict of interests.</p>
			</sec>
			<sec id="S0006" sec-type="supplementary-material">
				<title>Supplemental Material</title>
				<p>Supplemental data for this article can be accessed
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/15548627.2018.1522467">here</ext-link>.
				</p>
				<supplementary-material content-type="local-data" id="SM5212">
					<caption>
						<title>Supplemental Material</title>
					</caption>
					<media mimetype="application" mime-subtype="zip" xlink:href="kaup-15-03-1522467-s001.zip" orientation="portrait" id="d37e2133" position="anchor"/>
				</supplementary-material>
			</sec>
			<ref-list>
				<title>References</title>
				<ref id="CIT0001">
					<label>[1]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Lassmann</surname>
								<given-names>H</given-names>
							</name>,
							<name name-style="western">
								<surname>van Horssen</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Mahad</surname>
								<given-names>D.</given-names>
							</name>
						</person-group>
						<article-title>Progressive multiple sclerosis: pathology and pathogenesis</article-title>.
						<source>Nat Revi Neurol</source>.
						<year>2012</year>
						<month>11</month>
						<day>5</day>;
						<volume>8</volume>(
						<issue>11</issue>):
						<fpage>647</fpage>&#x2013;
						<lpage>656</lpage>.
						<comment>PubMed PMID: 23007702</comment>.
					</mixed-citation>
				</ref>
				<ref id="CIT0002">
					<label>[2]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Martin</surname>
								<given-names>R</given-names>
							</name>,
							<name name-style="western">
								<surname>Hernandez</surname>
								<given-names>M</given-names>
							</name>,
							<name name-style="western">
								<surname>Cordova</surname>
								<given-names>C</given-names>
							</name>, et al
						</person-group>
						<article-title>Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis</article-title>.
						<source>Br J Pharmacol</source>.
						<year>2012</year>
						<month>7</month>;
						<volume>166</volume>(
						<issue>5</issue>):
						<fpage>1708</fpage>&#x2013;
						<lpage>1723</lpage>.
						<comment>PubMed PMID: 22260389; PubMed Central PMCID: PMC3419913</comment>.
						<pub-id pub-id-type="pmid">22260389</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0003">
					<label>[3]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Goldmann</surname>
								<given-names>T</given-names>
							</name>,
							<name name-style="western">
								<surname>Prinz</surname>
								<given-names>M.</given-names>
							</name>
						</person-group>
						<article-title>Role of microglia in CNS autoimmunity</article-title>.
						<source>Clin Dev Immunol</source>.
						<year>2013</year>;
						<volume>2013</volume>:
						<fpage>208093</fpage>
						<comment>PubMed PMID: 23840238; PubMed Central PMCID: PMC3694374</comment>.
						<pub-id pub-id-type="pmid">23840238</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0004">
					<label>[4]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Ciccarelli</surname>
								<given-names>O</given-names>
							</name>,
							<name name-style="western">
								<surname>Barkhof</surname>
								<given-names>F</given-names>
							</name>,
							<name name-style="western">
								<surname>Bodini</surname>
								<given-names>B</given-names>
							</name>, et al
						</person-group>
						<article-title>Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging</article-title>.
						<source>Lancet Neurol</source>.
						<year>2014</year>
						<month>8</month>;
						<volume>13</volume>(
						<issue>8</issue>):
						<fpage>807</fpage>&#x2013;
						<lpage>822</lpage>.
						<comment>PubMed PMID: 25008549</comment>.
						<pub-id pub-id-type="pmid">25008549</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0005">
					<label>[5]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Singh</surname>
								<given-names>S</given-names>
							</name>,
							<name name-style="western">
								<surname>Metz</surname>
								<given-names>I</given-names>
							</name>,
							<name name-style="western">
								<surname>Amor</surname>
								<given-names>S</given-names>
							</name>, et al
						</person-group>
						<article-title>Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons</article-title>.
						<source>Acta Neuropathol</source>.
						<year>2013</year>
						<month>4</month>;
						<volume>125</volume>(
						<issue>4</issue>):
						<fpage>595</fpage>&#x2013;
						<lpage>608</lpage>.
						<comment>PubMed PMID: 23354834; PubMed Central PMCID: PMC3611040</comment>.
						<pub-id pub-id-type="pmid">23354834</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0006">
					<label>[6]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Merson</surname>
								<given-names>TD</given-names>
							</name>,
							<name name-style="western">
								<surname>Binder</surname>
								<given-names>MD</given-names>
							</name>,
							<name name-style="western">
								<surname>Kilpatrick</surname>
								<given-names>TJ.</given-names>
							</name>
						</person-group>
						<article-title>Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS</article-title>.
						<source>Neuromolecular Med</source>.
						<year>2010</year>
						<month>6</month>;
						<volume>12</volume>(
						<issue>2</issue>):
						<fpage>99</fpage>&#x2013;
						<lpage>132</lpage>.
						<comment>PubMed PMID: 20411441</comment>.
						<pub-id pub-id-type="pmid">20411441</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0007">
					<label>[7]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Liang</surname>
								<given-names>P</given-names>
							</name>,
							<name name-style="western">
								<surname>Le</surname>
								<given-names>W</given-names>
							</name>
						</person-group>
						<article-title>Role of autophagy in the pathogenesis of multiple sclerosis</article-title>.
						<source>Neurosci Bull</source>.
						<year>2015</year>
						<month>8</month>;
						<volume>31</volume>(
						<issue>4</issue>):
						<fpage>435</fpage>&#x2013;
						<lpage>444</lpage>.
						<comment>PubMed PMID: 26254059</comment>.
						<pub-id pub-id-type="pmid">26254059</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0008">
					<label>[8]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Zhen</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Feng</surname>
								<given-names>X</given-names>
							</name>,
							<name name-style="western">
								<surname>Li</surname>
								<given-names>Z</given-names>
							</name>, et al
						</person-group>
						<article-title>Suppression of murine experimental autoimmune encephalomyelitis development by 1,25-dihydroxyvitamin D3 with autophagy modulation</article-title>.
						<source>J Neuroimmunol</source>.
						<year>2015</year>
						<month>3</month>
						<day>15</day>;
						<volume>280</volume>:
						<fpage>1</fpage>&#x2013;
						<lpage>7</lpage>.
						<comment>PubMed PMID: 25773147</comment>.
						<pub-id pub-id-type="pmid">25773147</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0009">
					<label>[9]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Feng</surname>
								<given-names>X</given-names>
							</name>,
							<name name-style="western">
								<surname>Hou</surname>
								<given-names>H</given-names>
							</name>,
							<name name-style="western">
								<surname>Zou</surname>
								<given-names>Y</given-names>
							</name>, et al
						</person-group>
						<article-title>Defective autophagy is associated with neuronal injury in a mouse model of multiple sclerosis</article-title>.
						<source>Bosnian J Med Sci</source>.
						<year>2017</year>
						<month>5</month>
						<day>20</day>;
						<volume>17</volume>(
						<issue>2</issue>):
						<fpage>95</fpage>&#x2013;
						<lpage>103</lpage>.
						<comment>PubMed PMID: 28086065</comment>.
					</mixed-citation>
				</ref>
				<ref id="CIT0010">
					<label>[10]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Yan</surname>
								<given-names>Q</given-names>
							</name>,
							<name name-style="western">
								<surname>Han</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Wang</surname>
								<given-names>G</given-names>
							</name>, et al
						</person-group>
						<article-title>Activation of AMPK/mTORC1-mediated autophagy by metformin reverses Clk1 deficiency-sensitized dopaminergic neuronal death</article-title>.
						<source>Mol Pharmacol</source>.
						<year>2017</year>
						<month>12</month>;
						<volume>92</volume>(
						<issue>6</issue>):
						<fpage>640</fpage>&#x2013;
						<lpage>652</lpage>.
						<comment>PubMed PMID: 29025968</comment>.
						<pub-id pub-id-type="pmid">29025968</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0011">
					<label>[11]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Nash</surname>
								<given-names>Y</given-names>
							</name>,
							<name name-style="western">
								<surname>Schmukler</surname>
								<given-names>E</given-names>
							</name>,
							<name name-style="western">
								<surname>Trudler</surname>
								<given-names>D</given-names>
							</name>, et al
						</person-group>
						<article-title>DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia</article-title>.
						<source>J Neurochem</source>.
						<year>2017</year>
						<month>12</month>;
						<volume>143</volume>(
						<issue>5</issue>):
						<fpage>584</fpage>&#x2013;
						<lpage>594</lpage>.
						<comment>PubMed PMID: 28921554</comment>.
						<pub-id pub-id-type="pmid">28921554</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0012">
					<label>[12]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Zhou</surname>
								<given-names>X</given-names>
							</name>,
							<name name-style="western">
								<surname>Zhou</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Li</surname>
								<given-names>X</given-names>
							</name>, et al
						</person-group>
						<article-title>GSK-3beta inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury</article-title>.
						<source>Biochem Biophys Res Commun</source>.
						<year>2011</year>
						<month>7</month>
						<day>29</day>;
						<volume>411</volume>(
						<issue>2</issue>):
						<fpage>271</fpage>&#x2013;
						<lpage>275</lpage>.
						<comment>PubMed PMID: 21723251</comment>.
						<pub-id pub-id-type="pmid">21723251</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0013">
					<label>[13]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Mizushima</surname>
								<given-names>N</given-names>
							</name>
						</person-group>
						<article-title>Autophagy: process and function</article-title>.
						<source>Genes Dev</source>.
						<year>2007</year>
						<month>11</month>
						<day>15</day>;
						<volume>21</volume>(
						<issue>22</issue>):
						<fpage>2861</fpage>&#x2013;
						<lpage>2873</lpage>.
						<pub-id pub-id-type="pmid">18006683</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0014">
					<label>[14]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Gozuacik</surname>
								<given-names>D</given-names>
							</name>,
							<name name-style="western">
								<surname>Kimchi</surname>
								<given-names>A</given-names>
							</name>
						</person-group>
						<article-title>Autophagy as a cell death and tumor suppressor mechanism</article-title>.
						<source>Oncogene</source>.
						<year>2004</year>
						<month>4</month>
						<day>12</day>;
						<volume>23</volume>(
						<issue>16</issue>):
						<fpage>2891</fpage>&#x2013;
						<lpage>2906</lpage>.
						<comment>PubMed PMID: 15077152</comment>.
						<pub-id pub-id-type="pmid">15077152</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0015">
					<label>[15]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Ravikumar</surname>
								<given-names>B</given-names>
							</name>,
							<name name-style="western">
								<surname>Sarkar</surname>
								<given-names>S</given-names>
							</name>,
							<name name-style="western">
								<surname>Davies</surname>
								<given-names>JE</given-names>
							</name>, et al
						</person-group>
						<article-title>Regulation of mammalian autophagy in physiology and pathophysiology</article-title>.
						<source>Physiol Rev</source>.
						<year>2010</year>
						<month>10</month>;
						<volume>90</volume>(
						<issue>4</issue>):
						<fpage>1383</fpage>&#x2013;
						<lpage>1435</lpage>.
						<comment>PubMed PMID: 20959619</comment>.
						<pub-id pub-id-type="pmid">20959619</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0016">
					<label>[16]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Martinez Vicente</surname>
								<given-names>M</given-names>
							</name>,
							<name name-style="western">
								<surname>Cuervo</surname>
								<given-names>AM</given-names>
							</name>
						</person-group>
						<article-title>Autophagy and neurodegeneration: when the cleaning crew goes on strike</article-title>.
						<source>Lancet Neurol</source>.
						<year>2007</year>;
						<volume>6</volume>(
						<issue>4</issue>):
						<fpage>352</fpage>&#x2013;
						<lpage>361</lpage>.
						<pub-id pub-id-type="pmid">17362839</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0017">
					<label>[17]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Kimmelman</surname>
								<given-names>AC</given-names>
							</name>
						</person-group>
						<article-title>The dynamic nature of autophagy in cancer</article-title>.
						<source>Genes Dev</source>.
						<year>2011</year>
						<month>10</month>
						<day>1</day>;
						<volume>25</volume>(
						<issue>19</issue>):
						<fpage>1999</fpage>&#x2013;
						<lpage>2010</lpage>.
						<pub-id pub-id-type="pmid">21979913</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0018">
					<label>[18]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Mizushima</surname>
								<given-names>N</given-names>
							</name>,
							<name name-style="western">
								<surname>Levine</surname>
								<given-names>B</given-names>
							</name>
						</person-group>
						<article-title>Autophagy in mammalian development and differentiation [10.1038/ncb0910-823]</article-title>.
						<source>Nat Cell Biol</source>.
						<year>2010</year>;
						<volume>12</volume>(
						<issue>9</issue>):
						<fpage>823</fpage>&#x2013;
						<lpage>830</lpage>.
						<pub-id pub-id-type="pmid">20811354</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0019">
					<label>[19]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Rubinsztein David</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Mari&#xF1;o</surname>
								<given-names>G</given-names>
							</name>,
							<name name-style="western">
								<surname>Kroemer</surname>
								<given-names>G</given-names>
							</name>
						</person-group>
						<article-title>Autophagy and Aging</article-title>.
						<source>Cell</source>.
						<year>2011</year>;
						<volume>146</volume>(
						<issue>5</issue>):
						<fpage>682</fpage>&#x2013;
						<lpage>695</lpage>.
						<pub-id pub-id-type="pmid">21884931</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0020">
					<label>[20]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Lopez</surname>
								<given-names>A</given-names>
							</name>,
							<name name-style="western">
								<surname>Lee</surname>
								<given-names>SE</given-names>
							</name>,
							<name name-style="western">
								<surname>Wojta</surname>
								<given-names>K</given-names>
							</name>, et al
						</person-group>
						<article-title>A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction</article-title>.
						<source>Brain</source>.
						<year>2017</year>
						<month>4</month>
						<day>01</day>;
						<volume>140</volume>(
						<issue>4</issue>):
						<fpage>1128</fpage>&#x2013;
						<lpage>1146</lpage>.
						<comment>PubMed PMID: 28334843; PubMed Central PMCID: PMC5382950</comment>.
						<pub-id pub-id-type="pmid">28334843</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0021">
					<label>[21]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Wang</surname>
								<given-names>P</given-names>
							</name>,
							<name name-style="western">
								<surname>Miao</surname>
								<given-names>CY</given-names>
							</name>
						</person-group>
						<article-title>Autophagy in the disorders of central nervous system: vital and/or fatal?</article-title>
						<source>CNS Neurosci Ther</source>.
						<year>2012</year>
						<month>12</month>;
						<volume>18</volume>(
						<issue>12</issue>):
						<fpage>955</fpage>&#x2013;
						<lpage>956</lpage>.
						<comment>PubMed PMID: 23191986</comment>.
						<pub-id pub-id-type="pmid">23191986</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0022">
					<label>[22]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Abdel Fattah</surname>
								<given-names>E</given-names>
							</name>,
							<name name-style="western">
								<surname>Bhattacharya</surname>
								<given-names>A</given-names>
							</name>,
							<name name-style="western">
								<surname>Herron</surname>
								<given-names>A</given-names>
							</name>, et al
						</person-group>
						<article-title>Critical role for IL-18 in spontaneous lung inflammation caused by autophagy deficiency</article-title>.
						<source>J Immunol (Baltimore, Md 1950)</source>.
						<year>2015</year>
						<month>6</month>
						<day>01</day>;
						<volume>194</volume>(
						<issue>11</issue>):
						<fpage>5407</fpage>&#x2013;
						<lpage>5416</lpage>.
						<comment>PubMed PMID: 25888640; PubMed Central PMCID: PMC4433854</comment>.
					</mixed-citation>
				</ref>
				<ref id="CIT0023">
					<label>[23]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Wang</surname>
								<given-names>Q</given-names>
							</name>,
							<name name-style="western">
								<surname>Zeng</surname>
								<given-names>P</given-names>
							</name>,
							<name name-style="western">
								<surname>Liu</surname>
								<given-names>Y</given-names>
							</name>, et al
						</person-group>
						<article-title>Inhibition of autophagy ameliorates atherogenic inflammation by augmenting apigenin-induced macrophage apoptosis</article-title>.
						<source>Int Immunopharmacol</source>.
						<year>2015</year>
						<month>7</month>;
						<volume>27</volume>(
						<issue>1</issue>):
						<fpage>24</fpage>&#x2013;
						<lpage>31</lpage>.
						<comment>PubMed PMID: 25899084</comment>.
						<pub-id pub-id-type="pmid">25899084</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0024">
					<label>[24]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Mehrpour</surname>
								<given-names>M</given-names>
							</name>,
							<name name-style="western">
								<surname>Esclatine</surname>
								<given-names>A</given-names>
							</name>,
							<name name-style="western">
								<surname>Beau</surname>
								<given-names>I</given-names>
							</name>, et al
						</person-group>
						<article-title>Overview of macroautophagy regulation in mammalian cells</article-title>.
						<source>Cell Res</source>.
						<year>2010</year>
						<month>7</month>;
						<volume>20</volume>(
						<issue>7</issue>):
						<fpage>748</fpage>&#x2013;
						<lpage>762</lpage>.
						<comment>PubMed PMID: 20548331</comment>.
						<pub-id pub-id-type="pmid">20548331</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0025">
					<label>[25]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Mizushima</surname>
								<given-names>N</given-names>
							</name>,
							<name name-style="western">
								<surname>Yoshimori</surname>
								<given-names>T</given-names>
							</name>,
							<name name-style="western">
								<surname>Ohsumi</surname>
								<given-names>Y</given-names>
							</name>
						</person-group>
						<article-title>The role of Atg proteins in autophagosome formation</article-title>.
						<source>Annu Rev Cell Dev Biol</source>.
						<year>2011</year>;
						<volume>27</volume>:
						<fpage>107</fpage>&#x2013;
						<lpage>132</lpage>.
						<comment>PubMed PMID: 21801009</comment>.
						<pub-id pub-id-type="pmid">21801009</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0026">
					<label>[26]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Lemasters</surname>
								<given-names>JJ</given-names>
							</name>
						</person-group>
						<article-title>Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging</article-title>.
						<source>Rejuvenation Res. 2005 Spring</source>;
						<volume>8</volume>(
						<issue>1</issue>):
						<fpage>3</fpage>&#x2013;
						<lpage>5</lpage>.
						<comment>PubMed PMID: 15798367</comment>.
					</mixed-citation>
				</ref>
				<ref id="CIT0027">
					<label>[27]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Kirisako</surname>
								<given-names>T</given-names>
							</name>,
							<name name-style="western">
								<surname>Ichimura</surname>
								<given-names>Y</given-names>
							</name>,
							<name name-style="western">
								<surname>Okada</surname>
								<given-names>H</given-names>
							</name>, et al
						</person-group>
						<article-title>The reversible modification regulates the membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to vacuole targeting pathway</article-title>.
						<source>J Cell Biol</source>.
						<year>2000</year>
						<month>10</month>
						<day>16</day>;
						<volume>151</volume>(
						<issue>2</issue>):
						<fpage>263</fpage>&#x2013;
						<lpage>276</lpage>.
						<comment>PubMed PMID: 11038174; PubMed Central PMCID: PMC2192639</comment>.
						<pub-id pub-id-type="pmid">11038174</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0028">
					<label>[28]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Kabeya</surname>
								<given-names>Y</given-names>
							</name>,
							<name name-style="western">
								<surname>Mizushima</surname>
								<given-names>N</given-names>
							</name>,
							<name name-style="western">
								<surname>Ueno</surname>
								<given-names>T</given-names>
							</name>, et al
						</person-group>
						<article-title>LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing</article-title>.
						<source>Embo J</source>.
						<year>2000</year>
						<month>11</month>
						<day>1</day>;
						<volume>19</volume>(
						<issue>21</issue>):
						<fpage>5720</fpage>&#x2013;
						<lpage>5728</lpage>.
						<comment>PubMed PMID: 11060023; PubMed Central PMCID: PMC305793</comment>.
						<pub-id pub-id-type="pmid">11060023</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0029">
					<label>[29]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Tanida</surname>
								<given-names>I</given-names>
							</name>,
							<name name-style="western">
								<surname>Ueno</surname>
								<given-names>T</given-names>
							</name>,
							<name name-style="western">
								<surname>Kominami</surname>
								<given-names>E</given-names>
							</name>
						</person-group>
						<article-title>Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes</article-title>.
						<source>J Biol Chem</source>.
						<year>2004</year>
						<month>11</month>
						<day>12</day>;
						<volume>279</volume>(
						<issue>46</issue>):
						<fpage>47704</fpage>&#x2013;
						<lpage>47710</lpage>.
						<comment>PubMed PMID: 15355958</comment>.
						<pub-id pub-id-type="pmid">15355958</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0030">
					<label>[30]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Bjorkoy</surname>
								<given-names>G</given-names>
							</name>,
							<name name-style="western">
								<surname>Lamark</surname>
								<given-names>T</given-names>
							</name>,
							<name name-style="western">
								<surname>Brech</surname>
								<given-names>A</given-names>
							</name>, et al
						</person-group>
						<article-title>p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death</article-title>.
						<source>J Cell Biol</source>.
						<year>2005</year>
						<month>11</month>
						<day>21</day>;
						<volume>171</volume>(
						<issue>4</issue>):
						<fpage>603</fpage>&#x2013;
						<lpage>614</lpage>.
						<comment>PubMed PMID: 16286508; PubMed Central PMCID: PMC2171557</comment>.
						<pub-id pub-id-type="pmid">16286508</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0031">
					<label>[31]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Klionsky</surname>
								<given-names>DJ</given-names>
							</name>,
							<name name-style="western">
								<surname>Abdelmohsen</surname>
								<given-names>K</given-names>
							</name>,
							<name name-style="western">
								<surname>Abe</surname>
								<given-names>A</given-names>
							</name>, et al
						</person-group>
						<article-title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)</article-title>.
						<source>Autophagy</source>.
						<year>2016</year>;
						<volume>12</volume>(
						<issue>1</issue>):
						<fpage>1</fpage>&#x2013;
						<lpage>222</lpage>.
						<comment>PubMed PMID: 26799652; PubMed Central PMCID: PMC4835977</comment>.
						<pub-id pub-id-type="pmid">26799652</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0032">
					<label>[32]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Fu</surname>
								<given-names>LL</given-names>
							</name>,
							<name name-style="western">
								<surname>Wen</surname>
								<given-names>X</given-names>
							</name>,
							<name name-style="western">
								<surname>Bao</surname>
								<given-names>JK</given-names>
							</name>, et al
						</person-group>
						<article-title>MicroRNA-modulated autophagic signaling networks in cancer</article-title>.
						<source>Int J Biochem Cell Biol</source>.
						<year>2012</year>
						<month>5</month>;
						<volume>44</volume>(
						<issue>5</issue>):
						<fpage>733</fpage>&#x2013;
						<lpage>736</lpage>.
						<comment>PubMed PMID: 22342941</comment>.
						<pub-id pub-id-type="pmid">22342941</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0033">
					<label>[33]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Xu</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Wang</surname>
								<given-names>Y</given-names>
							</name>,
							<name name-style="western">
								<surname>Tan</surname>
								<given-names>X</given-names>
							</name>, et al
						</person-group>
						<article-title>MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis</article-title>.
						<source>Autophagy</source>.
						<year>2012</year>
						<month>6</month>;
						<volume>8</volume>(
						<issue>6</issue>):
						<fpage>873</fpage>&#x2013;
						<lpage>882</lpage>.
						<comment>PubMed PMID: 22441107; PubMed Central PMCID: PMC3427253</comment>.
						<pub-id pub-id-type="pmid">22441107</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0034">
					<label>[34]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Wang</surname>
								<given-names>Z</given-names>
							</name>,
							<name name-style="western">
								<surname>Yuan</surname>
								<given-names>B</given-names>
							</name>,
							<name name-style="western">
								<surname>Fu</surname>
								<given-names>F</given-names>
							</name>, et al
						</person-group>
						<article-title>Hemoglobin enhances miRNA-144 expression and autophagic activation mediated inflammation of microglia via mTOR pathway</article-title>.
						<source>Sci Rep</source>.
						<year>2017</year>
						<month>9</month>
						<day>19</day>;
						<volume>7</volume>(
						<issue>1</issue>):
						<fpage>11861</fpage>
						<comment>10.1038/s41598-017-12067-2. PubMed PMID: 28928406; PubMed Central PMCID: PMC5605685</comment>.
						<pub-id pub-id-type="pmid">28928406</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0035">
					<label>[35]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Jovicic</surname>
								<given-names>A</given-names>
							</name>,
							<name name-style="western">
								<surname>Roshan</surname>
								<given-names>R</given-names>
							</name>,
							<name name-style="western">
								<surname>Moisoi</surname>
								<given-names>N</given-names>
							</name>, et al
						</person-group>
						<article-title>Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes</article-title>.
						<source>J Neurosci</source>.
						<year>2013</year>;
						<volume>33</volume>(
						<issue>12</issue>):
						<fpage>5127</fpage>&#x2013;
						<lpage>5137</lpage>.
						<pub-id pub-id-type="pmid">23516279</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0036">
					<label>[36]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Sharaf-Eldin</surname>
								<given-names>WE</given-names>
							</name>,
							<name name-style="western">
								<surname>Kishk</surname>
								<given-names>NA</given-names>
							</name>,
							<name name-style="western">
								<surname>Gad</surname>
								<given-names>YZ</given-names>
							</name>, et al
						</person-group>
						<article-title>Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases</article-title>.
						<source>J Neurol Sci</source>.
						<year>2017</year>
						<month>12</month>
						<day>15</day>;
						<volume>383</volume>:
						<fpage>188</fpage>&#x2013;
						<lpage>198</lpage>.
						<comment>PubMed PMID: 29246612</comment>.
						<pub-id pub-id-type="pmid">29246612</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0037">
					<label>[37]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Cantoni</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Cignarella</surname>
								<given-names>F</given-names>
							</name>,
							<name name-style="western">
								<surname>Ghezzi</surname>
								<given-names>L</given-names>
							</name>, et al
						</person-group>
						<article-title>Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis</article-title>.
						<source>Acta Neuropathol</source>.
						<year>2017</year>
						<month>1</month>;
						<volume>133</volume>(
						<issue>1</issue>):
						<fpage>61</fpage>&#x2013;
						<lpage>77</lpage>.
						<comment>10.1007/s00401-016-1621-6. PubMed PMID: 27704281; PubMed Central PMCID: PMC5423756</comment>.
						<pub-id pub-id-type="pmid">27704281</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0038">
					<label>[38]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Neely</surname>
								<given-names>KM</given-names>
							</name>,
							<name name-style="western">
								<surname>Green</surname>
								<given-names>KN</given-names>
							</name>
						</person-group>
						<article-title>Presenilins mediate efficient proteolysis via the autophagosome-lysosome system</article-title>.
						<source>Autophagy</source>.
						<year>2011</year>
						<month>6</month>;
						<volume>7</volume>(
						<issue>6</issue>):
						<fpage>664</fpage>&#x2013;
						<lpage>665</lpage>.
						<comment>PubMed PMID: 21460614</comment>.
						<pub-id pub-id-type="pmid">21460614</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0039">
					<label>[39]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Han</surname>
								<given-names>HE</given-names>
							</name>,
							<name name-style="western">
								<surname>Kim</surname>
								<given-names>TK</given-names>
							</name>,
							<name name-style="western">
								<surname>Son</surname>
								<given-names>HJ</given-names>
							</name>, et al
						</person-group>
						<article-title>Activation of autophagy pathway suppresses the expression of iNOS, IL6 and cell death of LPS-stimulated microglia cells</article-title>.
						<source>Biomol Ther (Seoul)</source>.
						<year>2013</year>
						<month>1</month>;
						<volume>21</volume>(
						<issue>1</issue>):
						<fpage>21</fpage>&#x2013;
						<lpage>28</lpage>.
						<comment>PubMed PMID: 24009854; PubMed Central PMCID: PMC3762303</comment>.
						<pub-id pub-id-type="pmid">24009854</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0040">
					<label>[40]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Cheng</surname>
								<given-names>M</given-names>
							</name>,
							<name name-style="western">
								<surname>Liu</surname>
								<given-names>L</given-names>
							</name>,
							<name name-style="western">
								<surname>Lao</surname>
								<given-names>Y</given-names>
							</name>, et al
						</person-group>
						<article-title>MicroRNA-181a suppresses parkin-mediated mitophagy and sensitizes neuroblastoma cells to mitochondrial uncoupler-induced apoptosis</article-title>.
						<source>Oncotarget</source>.
						<year>2016</year>
						<month>7</month>
						<day>5</day>;
						<volume>7</volume>(
						<issue>27</issue>):
						<fpage>42274</fpage>&#x2013;
						<lpage>42287</lpage>.
						<comment>PubMed PMID: 27281615; PubMed Central PMCID: PMC5173134</comment>.
						<pub-id pub-id-type="pmid">27281615</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0041">
					<label>[41]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Xu</surname>
								<given-names>F</given-names>
							</name>,
							<name name-style="western">
								<surname>Li</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Ni</surname>
								<given-names>W</given-names>
							</name>, et al
						</person-group>
						<article-title>Peroxisome proliferator-activated receptor-gamma agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury</article-title>.
						<source>PloS one</source>.
						<year>2013</year>;
						<volume>8</volume>(
						<issue>1</issue>):
						<fpage>e55080</fpage>
						<comment>PubMed PMID: 23372817; PubMed Central PMCID: PMC3555818</comment>.
						<pub-id pub-id-type="pmid">23372817</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0042">
					<label>[42]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Lu</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Chen</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Xu</surname>
								<given-names>HG</given-names>
							</name>, et al
						</person-group>
						<article-title>MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy</article-title>.
						<source>Gastroenterology</source>.
						<year>2014</year>
						<month>1</month>;
						<volume>146</volume>(
						<issue>1</issue>):
						<fpage>188</fpage>&#x2013;
						<lpage>199</lpage>.
						<comment>PubMed PMID: 24036151; PubMed Central PMCID: PMC3870037</comment>.
						<pub-id pub-id-type="pmid">24036151</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0043">
					<label>[43]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Zhai</surname>
								<given-names>Z</given-names>
							</name>,
							<name name-style="western">
								<surname>Wu</surname>
								<given-names>F</given-names>
							</name>,
							<name name-style="western">
								<surname>Dong</surname>
								<given-names>F</given-names>
							</name>, et al
						</person-group>
						<article-title>Human autophagy gene ATG16L1 is post-transcriptionally regulated by MIR142-3p</article-title>.
						<source>Autophagy</source>.
						<year>2014</year>
						<month>3</month>;
						<volume>10</volume>(
						<issue>3</issue>):
						<fpage>468</fpage>&#x2013;
						<lpage>479</lpage>.
						<comment>PubMed PMID: 24401604; PubMed Central PMCID: PMC4077885</comment>.
						<pub-id pub-id-type="pmid">24401604</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0044">
					<label>[44]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Wang</surname>
								<given-names>IK</given-names>
							</name>,
							<name name-style="western">
								<surname>Sun</surname>
								<given-names>KT</given-names>
							</name>,
							<name name-style="western">
								<surname>Tsai</surname>
								<given-names>TH</given-names>
							</name>, et al
						</person-group>
						<article-title>MiR-20a-5p mediates hypoxia-induced autophagy by targeting ATG16L1 in ischemic kidney injury</article-title>.
						<source>Life Sci</source>.
						<year>2015</year>
						<month>9</month>
						<day>1</day>;
						<volume>136</volume>:
						<fpage>133</fpage>&#x2013;
						<lpage>141</lpage>.
						<comment>PubMed PMID: 26165754</comment>.
						<pub-id pub-id-type="pmid">26165754</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0045">
					<label>[45]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Sun</surname>
								<given-names>KT</given-names>
							</name>,
							<name name-style="western">
								<surname>Chen</surname>
								<given-names>MY</given-names>
							</name>,
							<name name-style="western">
								<surname>Tu</surname>
								<given-names>MG</given-names>
							</name>, et al
						</person-group>
						<article-title>MicroRNA-20a regulates autophagy related protein-ATG16L1 in hypoxia-induced osteoclast differentiation</article-title>.
						<source>Bone</source>.
						<year>2015</year>
						<month>4</month>;
						<volume>73</volume>:
						<fpage>145</fpage>&#x2013;
						<lpage>153</lpage>.
						<comment>PubMed PMID: 25485521</comment>.
						<pub-id pub-id-type="pmid">25485521</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0046">
					<label>[46]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Guo</surname>
								<given-names>L</given-names>
							</name>,
							<name name-style="western">
								<surname>Zhao</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Qu</surname>
								<given-names>Y</given-names>
							</name>, et al
						</person-group>
						<article-title>microRNA-20a inhibits autophagic process by targeting ATG7 and ATG16L1 and favors mycobacterial survival in macrophage cells</article-title>.
						<source>Front Cell Infect Microbiol</source>.
						<year>2016</year>;
						<volume>6</volume>:
						<fpage>134</fpage>
						<comment>PubMed PMID: 27803889; PubMed Central PMCID: PMC5067373</comment>.
						<pub-id pub-id-type="pmid">27803889</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0047">
					<label>[47]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Mizushima</surname>
								<given-names>N</given-names>
							</name>,
							<name name-style="western">
								<surname>Komatsu</surname>
								<given-names>M</given-names>
							</name>
						</person-group>
						<article-title>Autophagy: renovation of cells and tissues</article-title>.
						<source>Cell</source>.
						<year>2011</year>
						<month>11</month>
						<day>11</day>;
						<volume>147</volume>(
						<issue>4</issue>):
						<fpage>728</fpage>&#x2013;
						<lpage>741</lpage>.
						<comment>PubMed PMID: 22078875</comment>.
						<pub-id pub-id-type="pmid">22078875</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0048">
					<label>[48]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Kuballa</surname>
								<given-names>P</given-names>
							</name>,
							<name name-style="western">
								<surname>Nolte</surname>
								<given-names>WM</given-names>
							</name>,
							<name name-style="western">
								<surname>Castoreno</surname>
								<given-names>AB</given-names>
							</name>, et al
						</person-group>
						<article-title>Autophagy and the immune system</article-title>.
						<source>Annu Rev Immunol</source>.
						<year>2012</year>;
						<volume>30</volume>:
						<fpage>611</fpage>&#x2013;
						<lpage>646</lpage>.
						<comment>PubMed PMID: 22449030</comment>.
						<pub-id pub-id-type="pmid">22449030</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0049">
					<label>[49]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Masiero</surname>
								<given-names>E</given-names>
							</name>,
							<name name-style="western">
								<surname>Sandri</surname>
								<given-names>M</given-names>
							</name>
						</person-group>
						<article-title>Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles</article-title>.
						<source>Autophagy</source>.
						<year>2010</year>
						<month>2</month>;
						<volume>6</volume>(
						<issue>2</issue>):
						<fpage>307</fpage>&#x2013;
						<lpage>309</lpage>.
						<comment>PubMed PMID: 20104028</comment>.
						<pub-id pub-id-type="pmid">20104028</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0050">
					<label>[50]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Korkmaz</surname>
								<given-names>G</given-names>
							</name>,
							<name name-style="western">
								<surname>le Sage</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Tekirdag</surname>
								<given-names>KA</given-names>
							</name>, et al
						</person-group>
						<article-title>miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1</article-title>.
						<source>Autophagy</source>.
						<year>2012</year>
						<month>2</month>
						<day>1</day>;
						<volume>8</volume>(
						<issue>2</issue>):
						<fpage>165</fpage>&#x2013;
						<lpage>176</lpage>.
						<comment>PubMed PMID: 22248718</comment>.
						<pub-id pub-id-type="pmid">22248718</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0051">
					<label>[51]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Dorhoi</surname>
								<given-names>A</given-names>
							</name>,
							<name name-style="western">
								<surname>Iannaccone</surname>
								<given-names>M</given-names>
							</name>,
							<name name-style="western">
								<surname>Farinacci</surname>
								<given-names>M</given-names>
							</name>, et al
						</person-group>
						<article-title>MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment</article-title>.
						<source>J Clin Invest</source>.
						<year>2013</year>
						<month>11</month>
						<day>1</day>;
						<volume>123</volume>(
						<issue>11</issue>):
						<fpage>4836</fpage>&#x2013;
						<lpage>4848</lpage>.
						<comment>PubMed PMID: 24084739</comment>.
						<pub-id pub-id-type="pmid">24084739</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0052">
					<label>[52]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Xi</surname>
								<given-names>X</given-names>
							</name>,
							<name name-style="western">
								<surname>Zhang</surname>
								<given-names>C</given-names>
							</name>,
							<name name-style="western">
								<surname>Han</surname>
								<given-names>W</given-names>
							</name>, et al
						</person-group>
						<article-title>MicroRNA-223 is upregulated in active tuberculosis patients and inhibits apoptosis of macrophages by targeting FOXO3</article-title>.
						<source>Genet Test Mol Biomarkers</source>.
						<year>2015</year>
						<month>12</month>;
						<volume>19</volume>(
						<issue>12</issue>):
						<fpage>650</fpage>&#x2013;
						<lpage>656</lpage>.
						<comment>PubMed PMID: 26505221</comment>.
						<pub-id pub-id-type="pmid">26505221</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0053">
					<label>[53]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Shao</surname>
								<given-names>BZ</given-names>
							</name>,
							<name name-style="western">
								<surname>Wei</surname>
								<given-names>W</given-names>
							</name>,
							<name name-style="western">
								<surname>Ke</surname>
								<given-names>P</given-names>
							</name>, et al
						</person-group>
						<article-title>Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome</article-title>.
						<source>CNS Neurosci Ther</source>.
						<year>2014</year>
						<month>12</month>;
						<volume>20</volume>(
						<issue>12</issue>):
						<fpage>1021</fpage>&#x2013;
						<lpage>1028</lpage>.
						<comment>PubMed PMID: 25417929</comment>.
						<pub-id pub-id-type="pmid">25417929</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0054">
					<label>[54]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Weindel</surname>
								<given-names>CG</given-names>
							</name>,
							<name name-style="western">
								<surname>Richey</surname>
								<given-names>LJ</given-names>
							</name>,
							<name name-style="western">
								<surname>Bolland</surname>
								<given-names>S</given-names>
							</name>, et al
						</person-group>
						<article-title>B cell autophagy mediates TLR7-dependent autoimmunity and inflammation</article-title>.
						<source>Autophagy</source>.
						<year>2015</year>;
						<volume>11</volume>(
						<issue>7</issue>):
						<fpage>1010</fpage>&#x2013;
						<lpage>1024</lpage>.
						<comment>PubMed PMID: 26120731; PubMed Central PMCID: PMC4590645</comment>.
						<pub-id pub-id-type="pmid">26120731</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0055">
					<label>[55]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>van Loosdregt</surname>
								<given-names>J</given-names>
							</name>,
							<name name-style="western">
								<surname>Rossetti</surname>
								<given-names>M</given-names>
							</name>,
							<name name-style="western">
								<surname>Spreafico</surname>
								<given-names>R</given-names>
							</name>, et al
						</person-group>
						<article-title>Increased autophagy in CD4+ T cells of rheumatoid arthritis patients results in T-cell hyperactivation and apoptosis resistance</article-title>.
						<source>Eur J Immunol</source>.
						<year>2016</year>
						<month>10</month>
						<day>5</day>
						<comment>PubMed PMID: 27624289</comment> DOI:
						<pub-id pub-id-type="doi">10.1002/eji.201646375</pub-id>
					</mixed-citation>
				</ref>
				<ref id="CIT0056">
					<label>[56]</label>
					<mixed-citation publication-type="journal">
						<person-group person-group-type="author">
							<name name-style="western">
								<surname>Stromnes</surname>
								<given-names>IM</given-names>
							</name>,
							<name name-style="western">
								<surname>Goverman</surname>
								<given-names>JM</given-names>
							</name>
						</person-group>
						<article-title>Active induction of experimental allergic encephalomyelitis</article-title>.
						<source>Nat Protoc</source>.
						<year>2006</year>;
						<volume>1</volume>(
						<issue>4</issue>):
						<fpage>1810</fpage>&#x2013;
						<lpage>1819</lpage>.
						<comment>PubMed PMID: 17487163</comment>.
						<pub-id pub-id-type="pmid">17487163</pub-id>
					</mixed-citation>
				</ref>
			</ref-list>
		</back>
	</article>
	<article
		xmlns:xlink="http://www.w3.org/1999/xlink"
		xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
		<!--The publisher of this article does not allow downloading of the full text in XML form.-->
		<front>
			<journal-meta>
				<journal-id journal-id-type="nlm-ta">Mol Cell Biol</journal-id>
				<journal-id journal-id-type="iso-abbrev">Mol Cell Biol</journal-id>
				<journal-id journal-id-type="hwp">mcb</journal-id>
				<journal-id journal-id-type="pmc">mcb</journal-id>
				<journal-id journal-id-type="publisher-id">MCB</journal-id>
				<journal-title-group>
					<journal-title>Molecular and Cellular Biology</journal-title>
				</journal-title-group>
				<issn pub-type="ppub">0270-7306</issn>
				<issn pub-type="epub">1098-5549</issn>
				<publisher>
					<publisher-name>American Society for Microbiology</publisher-name>
					<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
				</publisher>
			</journal-meta>
			<article-meta>
				<article-id pub-id-type="pmid">33077497</article-id>
				<article-id pub-id-type="pmc">7849395</article-id>
				<article-id pub-id-type="publisher-id">00480-20</article-id>
				<article-id pub-id-type="doi">10.1128/MCB.00480-20</article-id>
				<article-categories>
					<subj-group subj-group-type="heading">
						<subject>Research Article</subject>
					</subj-group>
				</article-categories>
				<title-group>
					<article-title>Alternative Splicing and Cleavage of GLUT8</article-title>
					<alt-title alt-title-type="running-head">Alternative Splicing and Cleavage of GLUT8</alt-title>
					<alt-title alt-title-type="short-authors">Alexander et al.</alt-title>
				</title-group>
				<contrib-group>
					<contrib contrib-type="author" corresp="yes">
						<contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7830-8043</contrib-id>
						<name>
							<surname>Alexander</surname>
							<given-names>Caroline M.</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Martin</surname>
							<given-names>Joshua A.</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Oxman</surname>
							<given-names>Elias</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Kasza</surname>
							<given-names>Ildiko</given-names>
						</name>
						<xref ref-type="aff" rid="aff1">
							<sup>a</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Senn</surname>
							<given-names>Katherine A.</given-names>
						</name>
						<xref ref-type="aff" rid="aff2">
							<sup>b</sup>
						</xref>
					</contrib>
					<contrib contrib-type="author">
						<name>
							<surname>Dvinge</surname>
							<given-names>Heidi</given-names>
						</name>
						<xref ref-type="aff" rid="aff2">
							<sup>b</sup>
						</xref>
						<xref ref-type="author-notes" rid="fn1">&#x2020;</xref>
					</contrib>
					<aff id="aff1">
						<label>a</label>
						<addr-line>McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin&#x2014;Madison, Madison, Wisconsin, USA</addr-line>
					</aff>
					<aff id="aff2">
						<label>b</label>
						<addr-line>Department of Biomolecular Chemistry, School of Medicine and Public Health, University of Wisconsin&#x2014;Madison, Madison, Wisconsin, USA</addr-line>
					</aff>
				</contrib-group>
				<author-notes>
					<corresp id="cor1">Address correspondence to Caroline M. Alexander,
						<email>cmalexander@wisc.edu</email>.
					</corresp>
					<fn id="fn1" fn-type="deceased">
						<label>&#x2020;</label>
						<p>Deceased.</p>
					</fn>
					<fn fn-type="other">
						<p>
							<bold>Citation</bold> Alexander CM, Martin JA, Oxman E, Kasza I, Senn KA, Dvinge H. 2021. Alternative splicing and cleavage of GLUT8. Mol Cell Biol 41:e00480-20.
							<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.00480-20">https://doi.org/10.1128/MCB.00480-20</ext-link>.
						</p>
					</fn>
				</author-notes>
				<pub-date pub-type="epreprint">
					<day>19</day>
					<month>10</month>
					<year>2020</year>
				</pub-date>
				<pub-date pub-type="epub">
					<day>21</day>
					<month>12</month>
					<year>2020</year>
				</pub-date>
				<pub-date pub-type="collection">
					<month>1</month>
					<year>2021</year>
				</pub-date>
				<volume>41</volume>
				<issue>1</issue>
				<elocation-id>e00480-20</elocation-id>
				<history>
					<date date-type="received">
						<day>10</day>
						<month>9</month>
						<year>2020</year>
					</date>
					<date date-type="accepted">
						<day>1</day>
						<month>10</month>
						<year>2020</year>
					</date>
				</history>
				<permissions>
					<copyright-statement>Copyright &#xA9; 2020 American Society for Microbiology.</copyright-statement>
					<copyright-year>2020</copyright-year>
					<copyright-holder>American Society for Microbiology</copyright-holder>
					<license license-type="asm" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">
						<license-p>
							<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">All Rights Reserved</ext-link>.
						</license-p>
					</license>
				</permissions>
				<self-uri content-type="pdf" xlink:href="MCB.00480-20.pdf"/>
				<abstract abstract-type="precis">
					<p>The GLUT (
						<italic>SLC2</italic>) family of membrane-associated transporters are described as glucose transporters. However, this family is divided into three classes and, though the regulated transporter activity of class I proteins is becoming better understood, class III protein functions continue to be obscure. We have cataloged the relative expression and splicing of
						<italic>SLC2</italic> mRNA isomers in tumors and normal tissues, with a focus on breast tumors and cell lines. mRNA for the class III protein GLUT8 is the predominant
						<italic>SLC2</italic> species expressed alongside GLUT1 in many tissues, but GLUT8 mRNA exists mostly as an untranslated splice form in tumors.
					</p>
				</abstract>
				<abstract>
					<title>ABSTRACT</title>
					<p>The GLUT (
						<italic>SLC2</italic>) family of membrane-associated transporters are described as glucose transporters. However, this family is divided into three classes and, though the regulated transporter activity of class I proteins is becoming better understood, class III protein functions continue to be obscure. We have cataloged the relative expression and splicing of
						<italic>SLC2</italic> mRNA isomers in tumors and normal tissues, with a focus on breast tumors and cell lines. mRNA for the class III protein GLUT8 is the predominant
						<italic>SLC2</italic> species expressed alongside GLUT1 in many tissues, but GLUT8 mRNA exists mostly as an untranslated splice form in tumors. We confirm that GLUT8 is not presented at the cell surface and does not transport glucose directly. However, we reveal a lysosome-dependent reaction that cleaves the GLUT8 protein and releases the carboxy-terminal peptide to a separate vesicle population. Given the localization of GLUT8 at a major metabolic hub (the late endosomal/lysosomal interface) and its regulated cleavage reaction, we evaluated TXNIP-mediated hexosamine homeostasis and speculate that GLUT8 may function as a sensory component of this reaction.
					</p>
				</abstract>
				<kwd-group>
					<title>KEYWORDS</title>
					<kwd>GLUT8</kwd>
					<kwd>
						<italic>SLC2</italic>
					</kwd>
					<kwd>TXNIP</kwd>
					<kwd>alternative splicing</kwd>
					<kwd>breast cancer</kwd>
					<kwd>chromophobe renal cell carcinoma</kwd>
					<kwd>cleavage</kwd>
					<kwd>glucose transport</kwd>
					<kwd>late endosomal-lysosomal boundary</kwd>
					<kwd>metabolic sensor</kwd>
				</kwd-group>
				<funding-group>
					<award-group id="award1">
						<funding-source>
							<institution-wrap>
								<institution>National Cancer Institute (NCI)</institution>
							</institution-wrap>
						</funding-source>
						<award-id>P30 CA014520</award-id>
						<principal-award-recipient>
							<name>
								<surname>Alexander</surname>
								<given-names>Caroline</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Martin</surname>
								<given-names>Josh</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Senn</surname>
								<given-names>Katherine A.</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Kasza</surname>
								<given-names>Ildiko</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Dvinge</surname>
								<given-names>Heidi</given-names>
							</name>
						</principal-award-recipient>
					</award-group>
					<award-group id="award2">
						<funding-source>
							<institution-wrap>
								<institution>HHS | NIH | National Cancer Institute (NCI)</institution>
								<institution-id>https://doi.org/10.13039/100000054</institution-id>
							</institution-wrap>
						</funding-source>
						<award-id>T32 CA009135</award-id>
						<principal-award-recipient>
							<name>
								<surname>Martin</surname>
								<given-names>Josh</given-names>
							</name>
						</principal-award-recipient>
					</award-group>
					<award-group id="award3">
						<funding-source>
							<institution-wrap>
								<institution>HHS | NIH | National Institute of General Medical Sciences (NIGMS)</institution>
								<institution-id>https://doi.org/10.13039/100000057</institution-id>
							</institution-wrap>
						</funding-source>
						<award-id>GM113142</award-id>
						<principal-award-recipient>
							<name>
								<surname>Alexander</surname>
								<given-names>Caroline</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Martin</surname>
								<given-names>Josh</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Kasza</surname>
								<given-names>Ildiko</given-names>
							</name>
						</principal-award-recipient>
					</award-group>
					<award-group id="award4">
						<funding-source>
							<institution-wrap>
								<institution>HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</institution>
								<institution-id>https://doi.org/10.13039/100000069</institution-id>
							</institution-wrap>
						</funding-source>
						<award-id>P30 AR066524</award-id>
						<principal-award-recipient>
							<name>
								<surname>Alexander</surname>
								<given-names>Caroline</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Martin</surname>
								<given-names>Josh</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Senn</surname>
								<given-names>Katherine A.</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Kasza</surname>
								<given-names>Ildiko</given-names>
							</name>
						</principal-award-recipient>
						<principal-award-recipient>
							<name>
								<surname>Dvinge</surname>
								<given-names>Heidi</given-names>
							</name>
						</principal-award-recipient>
					</award-group>
				</funding-group>
				<counts>
					<count count="1" count-type="supplementary-material"/>
					<fig-count count="9"/>
					<table-count count="2"/>
					<equation-count count="0"/>
					<ref-count count="71"/>
					<page-count count="20"/>
					<word-count count="11144"/>
				</counts>
				<custom-meta-group>
					<custom-meta>
						<meta-name>cover-date</meta-name>
						<meta-value>January 2021</meta-value>
					</custom-meta>
				</custom-meta-group>
			</article-meta>
		</front>
	</article>
</pmc-articleset>